| Joint Appendix | |||||
|---|---|---|---|---|---|
| Ex. | Docket No. | Short Cite | Title | Author | Date |
| 001 | 459-2 | PLG Phase I Exp. Discl. | PLG's Phase I Expert Disclosure (October 25, 2024) | PLG | 10/25/2024 |
| 002 | 459-3 | PLG Phase I Rebuttal Exp. Discl. | PLG's Phase I Rebuttal Expert Disclosure (January 14, 2025) | PLG | 1/14/2025 |
| 003 | 459-4 | US Phase I Exp. Discl. | USA's Phase I Expert Disclosure (December 9, 2024) | United States | 12/9/2024 |
| 004 | 459-5 | Aral Rep. | Expert Report Prof Mustafa M Aral | Mustafa M Aral | 10/23/2024 |
| 005 | 459-6 | Aral Dep. Tr. | Deposition Transcript | Mustafa Aral | 2/6/2025 |
| 006 | 459-7 | Brigham 1st Rep. | Expert Report of Jay L Brigham, PhD | Jay Brigham | 12/9/2024 |
| 007 | 459-8 | Brigham 1st Rep. Err. | Phase I Expert Report Errata | Jay Brigham | 2/13/2025 |
| 008 | 459-9 | Brigham 1st MCL | Phase I Expert Report Reliance Materials, Attachments A-C | Jay Brigham | 12/16/2024 |
| 009 | 459-10 | Brigham 2d Rep. | Expert Report of Jay L Brigham, PhD | Jay Brigham | 2/7/2025 |
| 010 | 459-11 | Brigham 2d MCL | Phase II Expert Report Reliance Materials | Jay Brigham | 2/14/2025 |
| 011 | 459-12 | Brigham Dep. Tr. | Deposition Transcript | Jay Brigham | 3/27/2025 |
| 012 | 459-13 | Brigham Dep. Err. | Deposition Errata | Jay Brigham | 5/2/2025 |
| 013 | 459-14 | Hennet Rep. | Expert Report of Remy J-C Hennet | Remy J-C Hennet | 12/9/2024 |
| 014 | 459-15 | Hennet 1st Rep. Err. | Report Errata 12/16/2024 | Remy J-C Hennet | 12/16/2024 |
| 015 | 459-16 | Hennet 2d Rep. Err. | Report Errata 2/28/2025 | Remy J-C Hennet | 2/28/2025 |
| 016 | 459-17 | Hennet MCL | Expert Report Reliance Materials | Remy J-C Hennet | |
| 017 | 459-18 | Hennet Suppl. MCL | Expert Report Supplemental Reliance Materials | Remy J-C Hennet | |
| 018 | 459-19 | Hennet 1st Dep. Tr. | Deposition Transcript | Remy J-C Hennet | 3/20/2025 |
| 019 | 459-20 | Hennet 1st Dep. Err. | 3/20/2025 Deposition Errata | Remy J-C Hennet | |
| 020 | 459-21 | Hennet 2d Dep. Tr. | Deposition Transcript | Remy J-C Hennet | 6/4/2025 |
| 021 | 460-1 | Jones and Davis Rep. | Tarawa Terrace Flow and Transport Model Post-Audit | Norman L Jones & R Jeffery Davis | 10/25/2024 |
| 022 | 460-2 | Jones and Davis MCL | Materials Considered List Initial Report (Revised) | Norman L Jones & R Jeffery Davis | 11/5/2024 |
| 023 | 460-3 | Jones and Davis Rebuttal | Rebuttal Report Regarding Tarawa Terrace Flow and Transport Model Post-Audit | Norman L Jones & R Jeffery Davis | 1/14/2025 |
| 024 | 460-4 | Jones and Davis Rebuttal MCL | Materials Considered List Rebuttal Report | Norman L Jones & R Jeffery Davis | 1/21/2025 |
| 025 | 460-5 | Davis Dep. Tr. | Deposition Transcript | R Jeffrey Davis | 2/13/2025 |
| 026 | 460-6 | Davis Dep. Err. | Deposition Errata | R Jeffery Davis | 3/21/2025 |
| 027 | 460-7 | Jones Dep. Tr. | Deposition Transcript | Norman L Jones | 2/14/2025 |
| 028 | 460-8 | Jones Dep. Err. | Deposition Errata | Norman L Jones | 3/21/2025 |
| 029 | 461-1 | Kelman Rep. | Expert Report of Ari Kelman, PhD | Ari Kelman | 2/7/2025 |
| 030 | 461-2 | Kelman MCL | Expert Report Reliance Materials | Ari Kelman | 2/14/2025 |
| 031 | 461-3 | Kelman 1st Dep. Tr. | Deposition Transcript | Ari Kelman | 4/1/2025 |
| 032 | 461-4 | Kelman 2d Dep. Tr. | Deposition Transcript | Ari Kelman | 4/8/2025 |
| 033 | 461-5 | Kelman Dep. Err. | Deposition Errata | Ari Kelman | 5/6/2025 |
| 034 | 461-6 | Konikow Rebuttal | Rebuttal to Reports of Dr Alex Spiliotopoulos and Dr Remy J-C Hennet | Leonard F Konikow | 1/13/2025 |
| 035 | 461-7 | Konikow Dep. Tr. | Deposition Transcript | Leonard F Konikow | 2/25/2025 |
| 036 | 461-8 | Longley 1st Rep. | In re Camp Lejeune Water Litig, Master Case No 7:23-CV-897 (EDNC) Expert Report of Dr Kyle Longley December 7, 2024 | Kyle Longley | 12/7/2024 |
| 037 | 461-9 | Longley 1st MCL | Materials Considered List to Expert Report of Kyle Longley | Kyle Longley | 12/27/2024 |
| 038 | 461-10 | Longley 2d Rep. | Camp Lejeune Justice Act Litigation Rebuttal Report of Kyle Longley | Kyle Longley | 1/13/2025 |
| 039 | 461-11 | Longley 2d MCL | Materials Considered List to Phase I Rebuttal Report (Kyle Longley) | Kyle Longley | 1/23/2025 |
| 040 | 461-12 | Longley 3d Rep. | Response to Dr Brigham and Dr Kelman Reports dated 2/7/25 | Kyle Longley | 3/17/2025 |
| 041 | 461-13 | Longley 3d MCL | Material Considered List to Response to Dr Brigham and Dr Kelman Reports dated 2/7/25 | Kyle Longley | 3/18/2025 |
| 042 | 461-14 | Longley Dep. Tr. | Deposition Transcript | Kyle Longley | 4/3/2025 |
| 043 | 462-1 | Maslia Rep. | Expert Report of Morris L Maslia, PE, DWRE, DEE, Fellow EWRI | Morris L Maslia | 10/25/2024 |
| 044 | 462-2 | Maslia Suppl. Rep. | Supplemental Report of April 24, 2025 | Morris Maslia | 4/24/2025 |
| 045 | 462-3 | Maslia Rebuttal | Rebuttal Response to: Reports of Alexandros Spiliotopoulos, Remy J-C Hennet & Jay Brigham | Morris L Maslia | 1/14/2025 |
| 046 | 462-4 | Maslia Am. MCL | Revised Materials Considered List for Rebuttal Report | Morris L Maslia | 1/24/2025 |
| 047 | 462-5 | Maslia 1st Dep. Tr. | Deposition Transcript | Morris L Maslia | 9/26/2024 |
| 048 | 462-6 | Maslia 1st Dep. Err. | September 26, 2024 Deposition Errata | Morris Maslia | 9/26/2024 |
| 049 | 462-7 | Maslia 2d Dep. Tr. | Deposition Transcript | Morris L Maslia | 3/13/2025 |
| 050 | 462-8 | Maslia 2d Dep. Err. | May 29, 2025 Deposition Errata | Morris Maslia | 5/29/2025 |
| 051 | 462-9 | Maslia 3d Dep. Tr. | Deposition Transcript | Morris L Maslia | 5/29/2025 |
| 052 | 462-10 | Maslia 3d Dep. Err. | March 13, 2025 Deposition Errata | Morris Maslia | 3/13/2025 |
| 053 | 462-11 | Sabatini Rebuttal Rep. | Expert Rebuttal Report of David Sabatini, PhD, PE, BCEE | David Sabatini | 1/14/2025 |
| 054 | 462-12 | Sabatini MCL | Materials Considered - Expert Rebuttal Report of David Sabatini | David Sabatini | 1/21/2025 |
| 055 | 462-13 | Sabatini Suppl. MCL | Supplemental/Amended Materials Considered List- Expert Rebuttal Report of David Sabatini | David Sabatini | 4/9/2025 |
| 056 | 462-14 | Sabatini Dep. Tr. | Deposition Transcript | David Sabatini | 4/11/2025 |
| 057 | 462-15 | Sabatini Dep. Err. | Deposition Errata | David Sabatini | 4/24/2025 |
| 058 | 462-16 | Spiliotopoulos Rep. | Expert Report of Alexandros Spiliotopoulos, PhD | Alexandros Spiliotopoulos | 12/9/2024 |
| 058.1 | Bladder Cancer Reports | ||||
| 059 | 462-17 | Spiliotopoulos Rep. Err. | Errata to Report | Alexandros Spiliotopoulos | 2/28/2025 |
| 060 | 462-18 | Spiliotopoulos Suppl. MCL | Supplemental and Corrected Materials Considered List | Alexandros Spiliotopoulos | 2/28/2025 |
| 061 | 462-19 | Spiliotopoulos Dep. Tr. | Deposition Transcript | Alexandros Spiliotopoulos | 3/18/2025 |
| 062 | 462-20 | Spiliotopoulos Dep. Err. | 3/18/2025 Deposition Errata | Alexandros Spiliotopoulos | N/A |
| 063 | 463-2 | PLG Phase II Exp. Discl. | PLG's Phase II Expert Disclosure (December 9, 2024) | PLG | 12/9/2024 |
| 064 | 463-3 | PLG Phase II Rebuttal Exp. Discl. | PLG's Phase II Rebuttal Expert Disclosure (March 15, 2025) | PLG | 3/15/2025 |
| 065 | 463-4 | PLG Phase II Am. Rebuttal Exp. Discl. | PLG's Phase II Amended Rebuttal Expert Disclosure (April 15, 2025) | PLG | |
| 066 | 463-5 | US Phase II Exp. Discl. | USA's Phase II Expert Disclosure (Feb. 7, 2025) | United States | 2/7/2025 |
| 067 | 463-6 | Bird GC Rep. (Bladder) | Bird - General Causation Report - Bladder Cancer | Bird, Steven | 12/9/2024 |
| 068 | 463-7 | Bird GC MCL (Bladder) | Bird - Materials Considered List to Bladder Cancer | Bird, Steven | 12/16/2024 |
| 069 | 463-8 | Bird GC 1st Suppl. MCL (Bladder) | Bird - Supplemental Materials Considered List to Bladder Cancer - 1 | Bird, Steven | 4/24/2025 |
| 070 | 463-9 | Culp Rep. | RULE 26 REPORT OF STEPHEN H CULP, MD, PhD | Stephen H Culp | 12/9/2024 |
| 071 | 463-10 | Culp MCL | STEPHEN H CULP, MD, PhD’S RELIANCE FILES (Materials Considered List) | Stephen Culp | 12/16/2024 |
| 072 | 463-11 | Culp Suppl. MCL | DR STEPHEN CULP – SUPPLEMENTAL MATERIALS CONSIDERED | Stephen Culp | 4/24/2025 |
| 073 | 463-12 | Gilbert Rep. (Bladder) | General Causation Expert Report of KATHLEEN M GILBERT, PHD TCE, PCE, benzene and bladder cancer | Kathleen M Gilbert | 12/9/2024 |
| 074 | 463-13 | Gilbert MCL (Bladder) | Gilbert - Materials Considered List (Bladder) | Kathleen M Gilbert | |
| 075 | 463-14 | Goodman Rep. (Bladder) | Trichloroethylene, Perchloroethylene, Benzene, Vinyl Chloride, and trans-1,2-Dichloroethylene Exposure and Bladder Cancer Risk | Julie E Goodman | 2/7/2025 |
| 076 | 463-15 | Hatten GC Rep. (Bladder) | CAMP LEJEUNE: BLADDER CANCER EXPERT REPORT OF BENJAMIN HATTEN, MD, MPH | Benjamin Hatten | 12/9/2024 |
| 077 | 463-16 | Hatten GC MCL (Bladder) | Materials Considered List - Bladder Cancer Expert Report | Benjamin Hatten | |
| 078 | 463-17 | Hatten GC 1st Suppl. MCL | DR. BENJAMIN HATTEN – SUPPLEMENTAL MATERIALS CONSIDERED | Benjamin Hatten | 12/8/2024 |
| 079 | 463-18 | Hatten GC 2nd Suppl. MCL | DR. BENJAMIN HATTEN – SECOND SUPPLEMENTAL MATERIALS CONSIDERED LIST | Benjamin Hatten | 12/8/2024 |
| 080 | 464-1 | McCabe Rep. (Bladder) | GENERAL CAUSATION REPORT CAMP LEJEUNE WATER VOLATILE ORGANIC CHEMICALS AND KIDNEY CANCER | Michael J McCabe | 2/7/2025 |
| 081 | 464-2 | Plunkett Rep. | EXPERT REPORT OF LAURA M PLUNKETT, PHD, DABT | Laura Plunkett | 12/9/2024 |
| 082 | 464-3 | Plunkett Am. Rep. | AMENDED EXPERT REPORT OF LAURA M PLUNKETT, PHD, DABT | Laura Plunkett | 4/17/2025 |
| 083 | 464-4 | Bird GC Rep. (Kidney) | Bird - General Causation Report - Kidney Cancer | Bird, Steven | 12/9/2024 |
| 084 | 464-5 | Bird GC MCL (Kidney) | Bird - Materials Considered List to Kidney Cancer | Bird, Steven | 12/16/2024 |
| 085 | 464-6 | Bird GC 1st Suppl. MCL (Kidney) | Bird - Supplemental Materials Considered List to Kidney Cancer - 1 | Bird, Steven | 4/1/2025 |
| 086 | 464-7 | Freeman Rep. (Kidney) | RE: Camp Lejeune Water Contamination Litigation: Kidney cancer outcome | Michael D Freeman | 12/8/2024 |
| 087 | 464-8 | Freeman Suppl. MCL | Dr Michael Freeman - Supplemental Materials Considered | Michael Freeman | |
| 088 | 464-9 | Gilbert Rep. (Kidney) | General Causation Expert Report of KATHLEEN M GILBERT, PHD TCE and Kidney Cancer | Kathleen M Gilbert | 12/8/2024 |
| 089 | 464-10 | Gilbert MCL (Kidney) | Gilbert - Materials Considered List (Kidney) | Kathleen M Gilbert | |
| 090 | 464-11 | Hatten GC Rep. (Kidney) | CAMP LEJEUNE: KIDNEY CANCER EXPERT REPORT OF BENJAMIN HATTEN, MD, MPH | Benjamin Hatten | 12/8/2024 |
| 091 | 464-12 | Hatten GC Add'l MCL | DR. BENJAMIN HATTEN – ADDITIONAL MATERIALS CONSIDERED | Benjamin Hatten | 12/2024 |
| 092 | 464-13 | Mallon GC Rep. (Kidney) | General Causation Expert Report of Timothy M Mallon, MD, MPH, MS | Timothy M Mallon | 12/9/2024 |
| 093 | 464-14 | Mallon GC Suppl. MCL (Kidney) | General Causation - Kidney Cancer Supplemental Materials Considered | Timothy M Mallon | undated |
| 094 | 464-15 | Goodman Rep. (Kidney) | Trichloroethylene, Perchloroethylene, Benzene, Vinyl Chloride, and trans-1,2-Dichloroethylene Exposure and Kidney Cancer | Julie E Goodman | 2/7/2025 |
| 095 | 464-16 | McCabe Rep. (Kidney) | GENERAL CAUSATION REPORT CAMP LEJEUNE WATER VOLATILE ORGANIC CHEMICALS AND BLADDER CANCER | Michael J McCabe | 2/7/2025 |
| 096 | 465-1 | Gondek GC Rep. | Gondek - General Causation Report (Leukemia) | Gondek, Lukasz | 12/9/2024 |
| 097 | 465-2 | Gondek GC Suppl. MCL | Gondek - General Causation Supplemental Materials Considered List to Leukemia Report | Gondek, Lukasz | 4/4/2025 |
| 098 | 465-3 | Mallon GC Rep. (Leukemia) | General Causation Expert Report of Timothy M Mallon, MD, MPH, MS Leukemia | Timothy M Mallon | 12/9/2024 |
| 099 | 465-4 | Mallon GC MCL (Leukemia) | General Causation - Leukemia Materials Considered List | Timothy M Mallon | 12/16/2024 |
| 100 | 465-5 | Mallon GC 1st Suppl. MCL (Leukemia) | General Causation - Leukemia Supplemental Materials Considered | Timothy M Mallon | undated |
| 101 | 465-6 | Mallon GC 2d Suppl. MCL (Leukemia) | General Causation - Leukemia Supplemental Materials Considered (same title, but different materials added) | Timothy M Mallon | undated |
| 102 | 465-7 | Goodman Rep. (Leukemia) | Trichloroethylene, Perchloroethylene, Benzene, Vinyl Chloride, and trans-1,2-Dichloroethylene Exposure and Leukemia Risk | Julie E Goodman | 2/7/2025 |
| 103 | 465-8 | Bird GC Rep. (NHL-Leuk) | Bird - General Causation Report - NHL & Leukemia | Bird, Steven | 12/9/2024 |
| 104 | 465-9 | Bird GC MCL (NHL-Leuk) | Bird - Materials Considered List to NHL & Leukemia Report | Bird, Steven | 12/16/2024 |
| 105 | 465-10 | Bird GC 1st Suppl. MCL (NHL-Leuk) | Bird - Supplemental Materials Considered List to NHL & Leukemia Report - 0 | Bird, Steven | 4/4/2025 |
| 106 | 465-11 | Bird GC 2d Suppl. MCL (NHL-Leuk) | Bird - Supplemental Materials Considered List to NHL & Leukemia Report - 1 | Bird, Steven | 4/24/2025 |
| 107 | 466-1 | Felsher GC Rep. (NHL-Leuk) | General Causation Expert Report of Dean W Felsher, MD, PhD Leukemia & Non-Hodgkin Lymphoma | Dean W Felsher | 12/9/2024 |
| 108 | 466-2 | Gilbert Rep. (NHL-Leuk) | General Causation Expert Report of KATHLEEN M GILBERT, PHD TCE, Non-Hodgkin Lymphoma, and Leukemia | Kathleen M Gilbert | 12/9/2024 |
| 109 | 466-3 | Gilbert MCL (NHL-Leuk) | Gilbert - Materials Considered List (NHL-Leuk) | Kathleen M Gilbert | |
| 110 | 466-4 | Gilbert Suppl. MCL (NHL-Leuk) | Gilbert - Supplemental Materials Considered List (NHL-Leuk) | Kathleen M Gilbert | |
| 111 | 466-5 | Hu GC Rep. | General Causation Expert Report of Howard Hu, MD, MPH, ScD | Howard Hu | 12/9/2024 |
| 112 | 466-6 | Hu GC MCL | Howard Hu - Materials Considered List | Howard Hu | 12/16/2025 |
| 113 | 466-7 | McCabe Rep. (NHL-Leuk) | GENERAL CAUSATION REPORT CAMP LEJEUNE WATER VOLATILE ORGANIC CHEMICALS AND NON-HODGKIN’S LYMPHOMA AND LEUKEMIA | Michael J McCabe | 2/7/2025 |
| 114 | 466-8 | Hu GC Suppl. Rep. | January 31, 2025 Supplement to the December 9, 2024 General Causation Expert Report of Howard Hu, MD, MPH, ScD | Howard Hu | 1/31/2025 |
| 115 | 466-9 | Hu GC 1st Suppl. MCL | Howard Hu - Supplemental Materials Considered List 1 | Howard Hu | 4/24/2025 |
| 116 | 466-10 | Hu GC 2d Suppl. MCL | Howard Hu - Supplemental Materials Considered List 2 | Howard Hu | 4/29/2025 |
| 117 | 466-11 | Goodman Rep. (NHL) | Trichloroethylene, Perchloroethylene, Benzene, Vinyl Chloride, and trans-1,2-DCE Exposure and NHL Risk | Julie E Goodman | 2/7/2025 |
| 118 | 467-1 | Bird GC Rep. (PD) | Bird - General Causation Report - Parkinson's Disease | Bird, Steven | 12/9/2024 |
| 119 | 467-2 | Bird GC MCL (PD) | Bird - Materials Considered List to Parkinson's Disease | Bird, Steven | 12/16/2024 |
| 120 | 467-3 | Bird GC 2d Suppl. MCL (PD) | Bird - Supplemental Materials Considered List to Parkinson's Disease - 2 | Bird, Steven | 4/9/2025 |
| 121 | 467-4 | Boehme Rep. | Re: IN RE: CAMP LEJEUNE WATER LITIGATION IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA; Case No: 7:23-CV-897 | Amelia K Boehme | 12/8/2024 |
| 122 | 467-5 | Boehme Suppl. MCL | Supplemental Materials Considered | Amelia K Boehme | 4/9/2025 |
| 123 | 467-6 | Cannon Rep. | GENERAL CAUSATION REPORT: TETRACHLOROETHYLENE AND PARKINSON’S DISEASE | Jason Cannon | 12/8/2024 |
| 124 | 467-7 | Cannon Suppl. Rep. | SUPPLEMENTAL REPORT TO 12/08/2024 (SUBMITTED ON 12/09/2024) GENERAL CAUSATION REPORT: TETRACHLOROETHYLENE AND PD | Jason Cannon | 1/2/2025 |
| 125 | 467-8 | Cannon Rebuttal | EXPERT REBUTTAL TO DR GOODMAN’S REPORT, ENTITLED “TRICHLOROETHYLENE, PERCHLOROETHYLENE, BENZENE, VINYL CHLORIDE, AND TRANS-1,2-DICHLOROETHYLENE AND PARKINSON'S DISEASE” | Jason Cannon | 3/15/2025 |
| 126 | 467-9 | Cannon Suppl. MCL | Jason Cannon Supplemental Materials Considered List | Jason Cannon | |
| 127 | 467-10 | Costa Rep. | Lucio G Costa, PhD REPORT | Lucio Costa | 12/9/2024 |
| 128 | 467-11 | Costa Suppl. MCL | Lucio G Costa Materials Considered List | Lucio Costa | |
| 129 | 467-12 | De Miranda Rep. | Biological Mechanisms of Dopaminergic Neurotoxicity from Trichloroethylene Exposure | Briana De Miranda | 12/8/2024 |
| 130 | 467-13 | De Miranda Suppl. MCL | Supplemental Materials Considered | Briana De Miranda | 12/7/2024 |
| 131 | 467-14 | Freeman Rep. (PD) | RE: Camp Lejeune Water Contamination Litigation: Parkinson’s disease outcome | Michael Freeman | 12/6/2024 |
| 132 | 467-15 | Miller GC Rep. | Trichloroethylene and Parkinson's disease: an examination of causal associations at Camp Lejeune | Gary Miller | 12/7/2024 |
| 133 | 467-16 | Miller GC Suppl. MCL | Supplemental Materials Considered | Gary Miller | 12/7/2024 |
| 134 | 467-17 | Goodman Rep. (PD) | Trichloroethylene, Perchloroethylene, Benzene, Vinyl Chloride, and trans-1,2-Dichloroethylene and Parkinson's Disease | Julie E Goodman | 2/7/2025 |
| 135 | 468-1 | Shields Rep. | General Causation Peter G Shields, MD | Peter G Shields | 2/7/2025 |
| 136 | 468-2 | Bird GC MCL (Suppl) | Bird - Materials Considered List to Supplemental Report (ALL) | Bird, Steven | 2/12/2025 |
| 137 | 468-3 | Bird GC Suppl. Rep. | Bird - General Causation Report - Supplemental (ALL) | Bird, Steven | 2/4/2025 |
| 138 | 468-4 | Bird GC 1st Suppl. MCL | Bird - Supplemental Materials Considered List (ALL) - 1 | Bird, Steven | 2/4/2025 |
| 139 | 468-5 | Bird GC 2d Suppl. MCL | Bird - Supplemental Materials Considered List (ALL) - 2 | Bird, Steven | 5/6/2025 |
| 140 | 468-6 | Bird GC 3d Suppl. MCL | Bird - Supplemental Materials Considered List (ALL) - 3 | Bird, Steven | 5/8/2025 |
| 141 | 468-7 | Bird GC 4th Suppl. MCL | Bird - Supplemental Materials Considered List (ALL) - 4 | Bird, Steven | 5/12/2025 |
| 142 | 468-8 | Madigan Rebuttal | Comments on Camp Lejeune Defendants’ Reports David Madigan, PhD | David Madigan | 3/16/2025 |
| 143 | 468-9 | Madigan Suppl. MCL | General Causation Supp Materials Considered List | David Madigan | undated |
| 144 | 468-10 | Savitz Rebuttal | Rebuttal Report on Methodological Considerations in Epidemiological Studies: Evaluating Random Err.or and Statistical Significance Testing | David Savitz | 3/17/2025 |
| 145 | 468-11 | Goodman Suppl. MCL | Supplemental Materials Considered | Julie E Goodman | 2/7/2025 |
| 146 | 468-12 | Lipscomb Rep. | Expert Report of John C Lipscomb, PhD, DABT | John C Lipscomb | 2/7/2025 |
| 147 | 468-13 | Lipscomb Suppl. Rep. | Supplemental Expert Report of John C Lipscomb, PhD, DABT | John C Lipscomb | 2/28/2025 |
| 148 | 469-2 | Bird GC Dep. Tr. | Bird - General Causation Deposition Transcript | Bird, Steven | 5/14/2025 |
| 149 | 469-3 | Madigan Dep. Tr. | Deposition Transcript | David Madigan | 6/11/2025 |
| 150 | 469-4 | Madigan Dep. Err. | 6/11/2025 Deposition Errata | David Madigan | 6/11/2025 |
| 151 | 469-5 | Mallon GC Dep. Tr. | Deposition Transcript | Timothy M Mallon | 4/21/2025 |
| 152 | 469-6 | Savitz 1st Dep. Tr. | Deposition Transcript 61024 | David Savitz | 6/10/2024 |
| 153 | 469-7 | Savitz 2d Dep. Tr. | Deposition Transcript 71724 | David Savitz | 7/17/2024 |
| 154 | 469-8 | Savitz 3d Dep. Tr. | Deposition Transcript | David Savitz | 5/16/2025 |
| 155 | 469-9 | Culp Dep. Tr. | Deposition Transcript | Stephen Culp | 5/8/2025 |
| 156 | 469-10 | Culp Dep. Err. | Deposition Errata | Stephen Culp | 5/8/2025 |
| 157 | 469-11 | Plunkett Dep. Tr. | Deposition Transcript | Laura Plunkett | 5/12/2025 |
| 158 | 469-12 | Hatten GC Dep. Tr. | Deposition Transcript | Benjamin Hatten | 5/12/2025 |
| 159 | 469-13 | Freeman Dep. Tr. | Deposition Transcript | Michael Freeman | 6/17/2025 |
| 160 | 469-14 | Gondek GC Dep. Tr. | Gondek - General Causation Deposition Transcript | Gondek, Lukasz | 4/23/2025 |
| 161 | 469-15 | Gondek GC Dep. Err. | Gondek - General Causation Deposition Errata | Gondek, Lukasz | 6/5/2025 |
| 162 | 470-1 | Hu GC Dep. Tr. | Deposition Transcript - General Causation | Howard Hu | 4/30/2025 |
| 163 | 470-2 | Hu GC Dep. Err. | Howard Hu - Phase II Deposition Errata | Howard Hu | 6/16/2025 |
| 164 | 470-3 | Felsher GC Dep. Tr. | Deposition Transcript | Dean W Felsher | 5/8/2025 |
| 165 | 470-4 | Gilbert Dep. Tr. | Deposition Transcript | Kathleen M Gilbert | 4/11/2025 |
| 166 | 470-5 | Gilbert Dep. Err. | 4/11/2025 Deposition Errata | Kathleen M Gilbert | 4/11/2025 |
| 167 | 470-6 | Boehme Dep. Tr. | Deposition Transcript | Amelia K Boehme | 5/2/2025 |
| 168 | 470-7 | Cannon Dep. Tr. | Deposition Transcript | Jason Cannon | 4/21/2025 |
| 169 | 470-8 | Costa Dep. Tr. | Deposition Transcript | Lucio Costa | 5/5/2025 |
| 170 | 470-9 | De Miranda Dep. Tr. | Deposition Transcript | Briana De Miranda | 4/14/2025 |
| 171 | 470-10 | Miller GC Dep. Tr. | Deposition Transcript | Gary Miller | 4/8/2025 |
| 172 | 471-1 | Goodman Dep. Tr. | Deposition Transcript | Julie E Goodman | 4/29/2025 |
| 173 | 471-2 | Goodman Dep. Err. | Errata Sheet | Julie E Goodman | 6/13/2025 |
| 174 | 471-3 | Lipscomb Dep. Tr. | Deposition Transcript | John C Lipscomb | 5/14/2025 |
| 175 | 471-4 | Lipscomb Dep. Err. | Errata Sheet | John C Lipscomb | 6/24/2025 |
| 176 | 471-5 | McCabe Rep. Err. | Expert Report Errata Sheet | Michael J McCabe | |
| 177 | 471-6 | McCabe Dep. Tr. | Deposition Transcript | Michael J McCabe | 5/9/2025 |
| 178 | 471-7 | McCabe Dep. Err. | 5/9/2025 Deposition Errata | Michael J McCabe | 5/9/2025 |
| 179 | 471-8 | Shields 1st Dep. Tr. | Deposition Transcript | Peter G Shields | 5/12/2025 |
| 180 | 471-9 | Shields 2d Dep. Tr. | Deposition Transcript | Peter G Shields | 6/6/2025 |
| 181 | 472-2 | ATSDR 2016 VC Addendum | Addendum to the Toxicological Profile for Vinyl Chloride | ATSDR | 2016 |
| 182 | 472-3 | ATSDR 2017 Assessment | Assessment of the Evidence for the Drinking Water Contaminants at Camp Lejeune and Specific Cancers and Other Diseases | ATSDR | 7/9/1905 |
| 183 | 472-4 | ATSDR 2017 PHA | Public Health Assessment for Camp Lejeune Drinking Water | ATSDR | 7/9/1905 |
| 184 | 472-5 | ATSDR 2018 Morbidity Study | Morbidity Study of Former Marines, Employees, and Dependents Potentially Exposed to Contaminated Drinking Water at US Marine Corps Base Camp Lejeune | ATSDR | 2018 |
| 185 | 472-6 | ATSDR 2019 PCE | Toxicological Profile for Tetrachloroethylene | ATSDR | 2019 |
| 186 | 472-7 | ATSDR 2019 TCE | Toxicological Profile for Trichloroethylene | ATSDR | 2019 |
| 187 | 472-8 | ATSDR 2024 Benzene | Toxicological Profile for Benzene | ATSDR | 2024 |
| 188 | 472-9 | ATSDR 2024 VC | Toxicological Profile for Vinyl Chloride | ATSDR | 2024 |
| 189 | 472-10 | Bove 2014 Mort. Study - Civ. | Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study | Bove, F; Ruckart P; Maslia, M; Larson, T | 2014 |
| 190 | 472-11 | Bove 2014 Mort. Study - Mil. | Evaluation of mortality among marines and navy personnel exposed to contaminated drinking water at USMC base Camp Lejeune: a retrospective cohort study | Bove, F; Ruckart P; Maslia, M; Larson, T | 2014 |
| 191 | 472-12 | Bove 2024 Cancer Incid. Study | Cancer Incidence among Marines and Navy Personnel and Civilian Workers Exposed to Industrial Solvents in Drinking Water at US Marine Corps Base Camp Lejeune: A Cohort Study | Bove, F; Greek, A; Gatiba, R; Boehm, R; Mohnsen, M | 2024 |
| 192 | 472-13 | Bove 2024 Cancer Incid. Study - Preprint | Evaluation of cancer incidence among marines and navy personnel exposed to contaminated drinking water at USMC base Camp Lejeune: a cohort study | Bove, F | 2024 |
| 193 | 472-14 | Bove 2024 Mort. Study | Evaluation of mortality among Marines, Navy personnel, and civilian workers exposed to contaminated drinking water at USMC base Camp Lejeune: a cohort study | Bove, F | 2024 |
| 194 | 473-2 | EPA 1998 Benzene | Carcinogenic Effects of Benzene: An Update | US EPA | 1998 |
| 195 | 473-3 | EPA 2000 VC | IRIS summary for vinyl chloride | US EPA | 2000b |
| 196 | 473-4 | EPA 2011 TCE | Toxicological Review of Trichloroethylene (CAS No 79-01-6) in Support of Summary Information on the Integrated Risk Information System (IRIS) (Final | US EPA | 2011 |
| 197 | 473-5 | EPA 2012 PCE | Toxicological Review of Tetrachloroethylene (Perchloroethylene) (CAS No 127-18-4) in Support of Summary Information on the Integrated Risk Information System (IRIS) (Final) | US EPA | 2012 |
| 198 | 473-6 | EPA 2020 PCE Risk Eval. | Risk Evaluation for Perchloroethylene (Ethene, 1,1,2,2-Tetrachloro-) (CASRN: 127-18-4) (Final) | US EPA | 2020a |
| 199 | 473-7 | EPA 2020 TCE Risk Eval. | Risk Evaluation for Trichloroethylene (CASRN: 79-01-6) (Final | US EPA | 2020b |
| 200 | 473-8 | IARC 2012 Benzene | Benzene | International Agency for Research on Cancer (IARC) | 2012a |
| 201 | 473-9 | IARC 2014 Monograph 106 | IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 106: TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS | International Agency for Research on Cancer (IARC) | 2014 |
| 202 | 474-1 | IARC 2018 Monograph 120 | (p 1-64) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 202 | 474-2 | IARC 2018 Monograph 120 | (p 65-119) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 202 | 474-3 | IARC 2018 Monograph 120 | (p 120-172) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 202 | 475-1 | IARC 2018 Monograph 120 | (p 173-244) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 202 | 475-2 | IARC 2018 Monograph 120 | (p 245-286) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 202 | 475-3 | IARC 2018 Monograph 120 | (p 287-301) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 120: Benzene | International Agency for Research on Cancer (IARC) | 2018 |
| 203 | 476-1 | IOM 2003 Insectides and Solvents | Gulf War and Health - Volume 2: Insecticides and Solvents | Institute of Medicine (IOM) | 2003 |
| 204 | 476-2 | IOM 2015 VA Guidance | Review of VA Clinical Guidance for the Health Conditions Identified by the Camp Lejeune Legislation | Institute of Medicine (IOM) | 2015 |
| 205 | 476-3 | NRC 2009 Report | Contaminated Water Supplies at Camp Lejeune: Assessing Potential Health Effects | NRC | 2009 |
| 206 | 476-4 | NTP 2015 Monograph TCE | Report on Carcinogens Monograph on Trichloroethylene (Final) | National Toxicology Program (NTP) | 2015 |
| 207 | 476-5 | NTP 2021 Benzene | Benzene (CAS No 71-43-2) | National Toxicology Program (NTP) | 2021c |
| 208 | 477-1 | NTP 2021 PCE | Tetrachloroethylene (CAS No 127-18-4) | National Toxicology Program (NTP) | 2021b |
| 209 | 477-2 | NTP 2021 TCE | Trichloroethylene (CAS No 79-01-6) | National Toxicology Program (NTP) | 2021a |
| 210 | 477-3 | NTP 2021 Vinyl Halides | Vinyl Halides (Selected) | National Toxicology Program (NTP) | 2021d |
| 211 | 478-2 | Alanee 2015 | Trichloroethylene Is Associated with Kidney Cancer Mortality: A Population-based Analysis | Alanee | 2015 |
| 212 | 478-3 | Al-Zalabani 2016 | Modifiable risk factors for theprevention of bladder cancer: a systematic review of meta-analyses | Al-Zalabani et al | 2016 |
| 213 | 478-4 | Andrew 2002 | Kidney Cancer Risk Associated with Historic Groundwater Trichloroethylene Contamination | Andrew, AS | 2002 |
| 214 | 478-5 | Anttila 1995 | Cancer incidence among Finnish workers exposed to halogenated hydrocarbons | Anttila, A | 1995 |
| 215 | 478-6 | Asal 1988 | Risk factors in renal cell carcinoma: II Medical history, occupation, multivariate analysis, and conclusions | Asal, NR | 1988 |
| 216 | 478-7 | Aschengrau 1993 | Cancer risk and tetrachloroethylene contaminated drinking water in Massachusetts | Aschengrau, A | 1993 |
| 217 | 478-8 | Auperin 1994 | Occupational risk factors for renal cell carcinoma: A case-control study | Auperin, A | 1994 |
| 218 | 478-9 | Axelson 1994 | Updated and expanded Swedish cohort study on trichloroethylene and cancer risk | Axelson, O | 1994 |
| 219 | 478-10 | Bahr 2011 | Occupational exposure to trichloroethylene and cancer risk for workers at the Paducah Gaseous Diffusion Plant | Bahr, DE | 2011 |
| 220 | 478-11 | Blair 2003 | Extended mortality follow-up of a cohort of dry cleaners | Blair, A | 2003 |
| 221 | 478-12 | Blair 1989 | Mortality among United States Coast Guard marine inspectors | Blair, A | 1989 |
| 222 | 478-13 | Boice 1999 | Mortality among aircraft manufacturing workers | Boice, JD | 1999 |
| 223 | 478-14 | Boice 2006 | Mortality among Rocketdyne workers who tested rocket engines, 1948-1999 | Boice, JD | 2006 |
| 224 | 479-1 | Brownson 1988 | A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption | Brownson, RC | 1988 |
| 225 | 479-2 | Buhagen 2016 | Association between kidney cancer and occupational exposure to trichloroethylene | Buhagen, M | 2016 |
| 226 | 479-3 | Bulbulyan 1999 | Cancer mortality among women in the Russian printing industry | Bulbulyan | 1999 |
| 227 | 479-4 | Burns 1991 | Risk of urinary bladder cancer among Blacks and Whites: the role of cigarette use and occupation | Burns, PB and Swanson, GM | 1991 |
| 228 | 479-5 | Callahan 2019 | Extended mortality follow-up in a cohort of dry cleaners | Callahan | 2019 |
| 229 | 479-6 | Calvert 2011 | Mortality and end-stage renal disease incidence among dry cleaning workers | Calvert, GM | 2011 |
| 230 | 479-7 | Carreon 2014 | Coronary Artery Disease and Cancer Mortality in a Cohort of Workers Exposed to Vinyl Chloride, Carbon Disulfide, Rotating Shift Work, and o-Toluidine at a Chemical Manufacturing Plant | Carreon, T et al | 2014 |
| 231 | 479-8 | Chang 2003 | A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan | Chang, YM | 2003 |
| 232 | 479-9 | Charbotel 2006 | Case-control study on renal cell cancer and occupational exposure to trichloroethylene Part II: Epidemiological aspects | Charbotel, B | 2006 |
| 233 | 479-10 | Christensen 2013 | Risk of selected cancers due to occupational exposure to chlorinated solvents in a case-control study in Montreal | Christensen, KY | 2013 |
| 234 | 479-11 | Cohn 1994 | Drinking Water Contamination and the Incidence of Leukemia and Non-Hodgkin's Lymphoma | Cohn, P; Klotz, J; Bove, F; Berkowitz, M; Fagliano, J | 1994 |
| 235 | 479-12 | Collingwood 1996 | An updated cohort mortality study of workers at a northeastern United States petroleum refinery | Collingwood, KW | 1996 |
| 236 | 479-13 | Collins 2015 | Lymphatic and hematopoietic cancers among benzene-exposed workers | Collins, JJ | 2015 |
| 237 | 479-14 | Colt 2004 | Occupation and bladder cancer risk in a population-based case-control study in New Hampshire | Colt, JS et al | 2004 |
| 238 | 479-15 | Colt 2011 | Occupation and bladder cancer in a population-based case-control study in Northern New England | Colt, JS et al | 2011 |
| 239 | 479-16 | Consonni 1999 | Mortality study in an Italian oil refinery: Extension of the follow-up | Consonni, D | 1999 |
| 240 | 479-17 | Costa 1989 | A mortality cohort study in a north Italian aircraft factory | Costa, G; Merletti, F; Segnan, N | 1989 |
| 241 | 480-1 | Dagg 1992 | An updated cause specific mortality study of petroleum refinery workers | Dagg, TG et al | 1992 |
| 242 | 480-2 | Delahunt 1995 | Occupational risk for renal cell carcinoma A case-control study based on the New Zealand Cancer Registry | Delahunt, B | 1995 |
| 243 | 480-3 | DeMoulin 2024 | Occupational benzene exposure and cancer risk among Chinese men: A report from the Shanghai Men's Health Study | DeMoulin, D | 2024 |
| 244 | 480-4 | Divine 1999a | Update of the Texaco mortality study 1947-93: Part I Analysis of overall patterns of mortality among refining, research, and petrochemical workers | Divine, BJ; Hartman, CM; Wendt, JK | 1999a |
| 245 | 480-5 | Divine 1999b | Update of the Texaco mortality study 1947-93: Part II Analyses of specific causes of death for white men employed in refining, research, and petrochemicals | Divine, BJ; Hartman, CM; Wendt, JK | 1999b |
| 246 | 480-6 | Dosemeci 1999 | Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons | Dosemeci, M | 1999 |
| 247 | 480-7 | Dryson 2008 | Case-control study of high risk occupations for bladder cancer in New Zealand | Dryson, E et al | 2008 |
| 248 | 480-8 | Flaig 2024 | NCCN Guidelines® Insights: Bladder Cancer, Version 32024: FeaturedUpdates to the NCCN Guidelines | TW Flaig et al | 2024 |
| 249 | 480-9 | Gaertner 2004 | A case-control study of occupational risk factors for bladder cancer in Canada | Gaertner, RRW | 2004 |
| 250 | 480-10 | Garabrant 1988 | Mortality and aircraft manufacturing workers in southern California | Garabrant, DH | 1988 |
| 251 | 480-11 | Gerin 1998 | Associations between several sites of cancer and occupational exposure to benzene, toluene, xylene, and styrene: Results of a case-control study in Montreal | Gérin, M | 1998 |
| 252 | 480-12 | Goldman 2012 | Solvent Exposures and Parkinson Disease Risk in Twins | Samuel M Goldman et al | 7/4/1905 |
| 253 | 480-13 | Goldman 2023 | Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune | Samuel M Goldman et al | 7/15/1905 |
| 254 | 480-14 | Goldman 2024 | Parkinson’s Disease Progression and Exposure to Contaminated Water at Camp Lejeune | Samuel M Goldman et al | 7/16/1905 |
| 255 | 480-15 | Greenland 1994 | A case-control study of cancer mortality at a transformer-assembly facility | Greenland, S | 1994 |
| 256 | 480-16 | Gun 2006 | Update of mortality and cancer incidence in the Australian petroleum industry cohort | Gun, RT; Pratt, N; Ryan, P; Roder, D | 2006 |
| 257 | 481-1 | Halaseh 2022 | A Review of the Etiology and Epidemiology of Bladder Cancer: All You Need to Know | Halaseh et al | 2022 |
| 258 | 481-2 | Hansen 2001 | Cancer incidence among Danish workers exposed to trichloroethylene | Hansen, J | 2001 |
| 259 | 481-3 | Hansen 2013 | Risk of cancer among workers exposed to trichloroethylene: Analysis of three Nordic cohort studies | Hansen, J | 2013 |
| 260 | 481-4 | Honda 1995 | An updated study of mortality among workers at a petroleum manufacturing plant | Honda, Y | 1995 |
| 261 | 481-5 | Hu 2002 | Renal cell carcinoma and occupational exposure to chemicals in Canada | Hu, J | 2002 |
| 262 | 481-6 | Huebner 2004 | Mortality Updates (1970-1997) of Two Refinery/Petrochemical Plant Cohorts at Baton Rouge, Louisiana, and Baytown, Texas | Huebner, WW | 2004 |
| 263 | 481-7 | Jensen 1988 | The Copenhagen case-control study of renal pelvis and ureter cancer: Role of smoking and occupational exposure | Jensen, OM | 1988 |
| 264 | 481-8 | Karami 2012 | Occupational trichloroethylene exposure and kidney cancer risk: A meta-analysis | Karami, S | 2012 |
| 265 | 481-9 | Katz 1981 | Female Laundry and Dry Cleaning Workers in Wisconsin: A Mortality Analysis | katz and jowett | 1981 |
| 266 | 481-10 | Kelsh 2010 | Occupational trichloroethylene exposure and kidney cancer: a meta-analysis | Kelsh, MA | 2010 |
| 267 | 481-11 | Koh 2011 | Lymphohematopoietic Cancer Mortality and Morbidity of Workers in a Refinery / Petrochemical Complex in Korea | Koh, DH et al | 2011 |
| 268 | 482-1 | Lewis 2000 | Mortality Among Three Refinery / Petrochemical Plant Cohorts I 1970 to 1982 Active/Terminated Workers | Lewis, RJ | 2000 |
| 269 | 482-2 | Lewis 2003 | Mortality and cancer morbidity in a cohort of Canadian petroleum workers | Lewis | 2003 |
| 270 | 482-3 | Linet 2015 | A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers | Linet, MS et al | 2015 |
| 271 | 482-4 | Lipworth 2011 | Cancer mortality among aircraft manufacturing workers: An extended follow-up | Lipworth, L | 2011 |
| 272 | 482-5 | Lynge 1997 | Risk of cancer and exposure to gasoline vapors | Lynge, E | 1997 |
| 273 | 482-6 | Ma 2009 | Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH–AARP Cohort | ma j, et al | 2009 |
| 274 | 482-7 | Mandel 1995 | International renal cell cancer study: IV. Occupation | Mandel, JS | 1995 |
| 275 | 482-8 | Mattioli 2002 | Occupational risk factors for renal cell cancer: A case-control study in northern Italy | Mattioli, S | 2002 |
| 276 | 482-9 | Mellemgaard 1994 | Occupational risk factors for renal-cell carcinoma in Denmark | Mellemgaard, A | 1994 |
| 277 | 482-10 | Michalek 2019 | Heavy metals, welding fumes, and other occupational exposures, and the risk of kidney cancer: A population-based nested case-control study in three Nordic countries | Michalek, IM | 2019 |
| 278 | 482-11 | Moore 2010 | Occupational trichloroethylene exposure and renal carcinoma risk: Evidence of genetic susceptibility by reductive metabolism gene variants | Moore, LE | 2010 |
| 279 | 482-12 | Morgan 1998 | Mortality of aerospace workers exposed to trichloroethylene | Morgan, RW | 1998 |
| 280 | 482-13 | Mundt 2000 | Historical cohort studies of 10109 men in the North American vinyl chloride industry, 1942-1972: Update of cancer mortality to 31 December 1995 | Mundt, KA | 2000 |
| 281 | 482-14 | Mundt 2017 | Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013 | Mundt, KA | 2017 |
| 282 | 483-1 | Parker 1981 | Woburn: Cancer Incidence and Environmental Hazards 1969 – 1978 | Parker, GS | 1981 |
| 283 | 483-2 | Pesch 2000a | Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany | Pesch | 2000 |
| 284 | 483-3 | Pesch 2000b | Occupational risk factors for urothelial carcinoma: Agent-specific results from a case-control study in Germany | Pesch | 2000 |
| 285 | 483-4 | Pukkala 1998 | Cancer Incidence Among Finnish Oil Refinery Workers, 1971-1994 | Pukkala, E | 1998 |
| 286 | 483-5 | Purdue 2017 | Occupational exposure to chlorinated solvents and kidney cancer: A case-control study | Purdue, MP | 2017 |
| 287 | 483-6 | Raaschou-Nielsen 2003 | Cancer risk among workers at Danish companies using trichloroethylene: A cohort study | Raaschou-Nielsen, O | 2003 |
| 288 | 483-7 | Radican 2008 | Mortality of Aircraft Maintenance Workers Exposed to Trichloroethylene and Other Hydrocarbons and Chemicals: Extended Follow-Up | Radican, L | 2008 |
| 289 | 483-8 | Ritz 1999 | Cancer mortality among workers exposed to chemicals during uranium processing | Ritz, B | 1999 |
| 290 | 483-9 | Ruder 1994 | Cancer mortality in female and male dry-cleaning workers | Ruder, AM | 1994 |
| 291 | 484-2 | Saginala 2020 | Epidemiology of Bladder Cancer | Saginala et al | 2020 |
| 292 | 484-3 | Satin 1996 | A 50-year mortality follow-up of a large cohort of oil refinery workers in Texas | Satin, KP | 1996 |
| 293 | 484-4 | Savitz 2023 | Epidemiology and the Law (Juris Publishing, Inc) | David A Savitz and Stephen G Schwartz | 2023 |
| 294 | 484-5 | Schoenberg 1984 | Case-Control Study of Bladder Cancer in New Jersey: I. Occupational Exposures in White Males | Schoenberg, JB et al | 1984 |
| 295 | 484-6 | Sciannameo 2019 | New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies | Sciannameo, V et al | 2019 |
| 296 | 484-7 | Scott 2011 | Trichloroethylene and cancer: Systematic and quantitative review of epidemiologic evidence for identifying hazards | Scott, CS | 2011 |
| 297 | 484-8 | Selden 2011 | Cancer morbidity in Swedish dry-cleaners and laundry workers: historically prospective cohort study | Selden, A and Ahlborg, G | 2011 |
| 298 | 484-9 | Seyyedsalehi 2024 | Occupational benzene exposure and risk of kidney and bladder cancers: A systematic review and meta-analysis | Seyyedsalehi, MS | 2024 |
| 299 | 484-10 | Shannon 1988 | Cancer Morbidity in Lamp Manufacturing Workers | Shannon, HS et al | 1988 |
| 300 | 484-11 | Siemiatycki 1994 | Occupational Risk Factors for Bladder Cancer: Results from a Case-Control Study in Montreal, Quebec, Canada | Siemiatycki, J; Dewar, R; Nadon, L; Gerin, M | 1994 |
| 301 | 484-12 | Silver 2014 | Retrospective cohort study of a microelectronics and business machine facility | Silver, SR | 2014 |
| 302 | 484-13 | Silverman 1990 | Occupational Risks of Bladder Cancer Among White Women in the United States | Silverman, DT; Levin, LI; Hoover, RN | 1990 |
| 303 | 484-14 | Sinks 1992 | Renal Cell Cancer among Paperboard Printing Workers | Sinks, T et al | 1992 |
| 304 | 484-15 | Sorahan 2002 | Mortality of United Kingdom oil refinery and petroleum distribution workers | Sorahan, T | 2002 |
| 305 | 484-16 | Sorahan 2005 | Cancer risks in a historical UK cohort of benzene exposed workers | Sorahan, T | 2005 |
| 306 | 485-1 | Steineck 1990a | Increased Risk of Urothelial Cancer in Stockholm During 1985-87 After Exposure to Benzene and Exhausts | Steineck, G et al | 1990a |
| 307 | 485-2 | Steineck 1990b | Vitamin A Supplements, Fried Foods, Fat And Urothelial Cancer A Case-Referent Study In Stockholm In 1985-87 | Steineck, G et al | 1990b |
| 308 | 485-3 | Sung 2007 | Increased standardized incidence ratio of breast cancer in female electronics workers | Sung, TI | 2007 |
| 309 | 485-4 | Swanson 1995 | Cancer Incidence Among Women in the Workplace: A Study of the Association Between Occupation and Industry and 11 Cancer Sites | Swanson, GM and Burns, PB | 1995 |
| 310 | 485-5 | Teschke 1997 | Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens | Teschke, K et al | 1997 |
| 311 | 485-6 | Teta 1990 | Mortality surveillance in a large chemical company: The Union Carbide Corporation experience, 1974-1983 | Teta, MJ | 1990 |
| 312 | 485-7 | Travier 2002 | Cancer incidence of dry cleaning, laundry and ironing workers in Sweden | Travier, N et al | 2002 |
| 313 | 485-8 | Tsai 1993 | A cohort mortality study of two California refinery and petrochemical plants | Tsai, SP | 1993 |
| 314 | 485-9 | Tsai 1996 | Long-Term Follow-Up Mortality Study of Petroleum Refinery and Chemical Plant Employees | Tsai, SP | 1996 |
| 315 | 485-10 | Tsai 2003 | mortality and morbidity study of refinery and petrochemical employees in Louisiana California refinery and petrochemical plants | Tsai, SP | 2003 |
| 316 | 485-11 | Tsai 2007 | A 56-Year Mortality Follow-Up of Texas Petroleum Refinery and Chemical Employees, 1948-2003 | Tsai, SP | 2007 |
| 317 | 486-1 | Vlaanderen 2013 | Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries | Vlaanderen, J | 2013 |
| 318 | 486-2 | Wang 2023 | Long-Term Exposure to Low Concentrations of Ambient Benzene and Mortality in a National English Cohort | Wang, J; Ma, Y; Tang, L; Li, D; Xie, J; Sun, Y; Tian Y | 7/15/1905 |
| 319 | 486-3 | Wong 1987a | An industry wide mortality study of chemical workers occupationally exposed to benzene II Dose response analyses | Wong, O | 1987a |
| 320 | 486-4 | Wong 1987b | An industry wide mortality study of chemical workers occupationally exposed to benzene II Dose response analyses | Wong, O | 1987b |
| 321 | 486-5 | Wong 2001a | Updated mortality study of workers at a petroleum refinery in Torrance, California, 1959 to 1997 | Wong, O | 2001a |
| 322 | 486-6 | Wong 2001b | An updated mortality study of workers at a petroleum refinery in Beaumont, Texas, 1945 to 1996 | Wong, O | 2001b |
| 323 | 486-7 | Yu 2025 | Long-term exposure to low-level ambient BTEX and site-specific cancer risk: A national cohort study in the UK Biobank | Yu, K; Xiong, Y; Chen, R; Cai, J; Huang, Y; Kan, H | 2025 |
| 324 | 486-8 | Zhao 2005 | Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers | Zhao, Y | 2005 |
| 325 | 486-9 | Zheng 2002 | Occupational and Bladder Cancer: A Population-Based, Case-Control Study in Iowa | Zheng, T et al | 2002 |
| 326 | 487-2 | PLG Phase III 2d Am. Exp. Discl. | PLG's Phase III Second Amended Expert Disclosure (March 31, 2025) | PLG | 3/31/2025 |
| 327 | 487-3 | PLG Phase III Rebuttal Exp. Discl. | PLG's Phase III Rebuttal Expert Disclosure (May 14, 2025) | PLG | 5/14/2025 |
| 328 | 487-4 | US Phase III Exp. Discl. | USA's Phase III Expert Disclosure (April 8, 2025) | United States | 4/8/2025 |
| 329 | 487-5 | Bird SC Rep. (Cagiano) | Bird - Specific Causation Report - Mark Cagiano | Steven B Bird | 2/7/2025 |
| 330 | 487-6 | Bird SC Am. Rep. (Cagiano) | Bird - Specific Causation Report - Mark Cagiano - 2 | Bird, Steven | 6/11/2025 |
| 331 | 487-7 | Bird SC Rep. (Criswell) | Bird - Specific Causation Report - Mike Criswell | Steven B Bird | 2/7/2025 |
| 332 | 487-8 | Bird SC Am. Rep. (Criswell) | Bird - Specific Causation Report - Mike Criswell - 2 | Bird, Steven | 6/11/2025 |
| 333 | 487-9 | Bird SC Rep. (Dyer) | Bird - Specific Causation Report - Terry Dyer - 3 | Bird, Steven | 6/11/2025 |
| 334 | 487-10 | Bird SC Am. Rep. (Dyer) | Bird - Specific Causation Report - Terry Dyer | Steven B Bird | 2/7/2025 |
| 335 | 487-11 | Bird SC Suppl. Rep. (Dyer) | Bird - Specific Causation Report - Terry Dyer 2 | Steven B Bird | 2/14/2025 |
| 336 | 487-12 | Bird SC Rep. (Laramore) | Bird - Specific Causation Report - Jimmy Laramore | Steven B Bird | 2/7/2025 |
| 337 | 487-13 | Bird SC Am. Rep. (Laramore) | Bird - Specific Causation Report - Jimmy Laramore - 2 | Bird, Steven | 6/11/2025 |
| 338 | 488-1 | Bird SC Rep. (Raymond) | Bird - Specific Causation Report - Edward Raymond | Steven B Bird | 2/7/2025 |
| 339 | 488-2 | Bird SC Am. Rep. (Raymond) | Bird - Specific Causation Report - Edward Raymond - 2 | Bird, Steven | 6/11/2025 |
| 340 | 488-3 | Bird SC Suppl. MCL (Bladder) | Bird - Supplemental Materials Considered List to Bladder Cancer Plaintiffs | Bird, Steven | 7/16/2025 |
| 341 | 488-4 | Bivins Rep. (Raymond) | Specific Causation Expert Report for Edward Raymond | Vincent Bivins | 2/7/2025 |
| 342 | 488-5 | Hatten SC Rep. (Cagiano) | Re: Camp Lejeune (Cagiano) | Benjamin Hatten | 2/7/2025 |
| 343 | 488-6 | Hatten SC Rep. (Criswell) | Re: Camp Lejeune (Criswell) | Benjamin Hatten | 2/7/2025 |
| 344 | 488-7 | Hatten SC Rep. (Dyer) | Re: Camp Lejeune (Dyer) | Benjamin Hatten | 2/7/2025 |
| 345 | 488-8 | Hatten SC Rep. (Laramore) | Re: Camp Lejeune (Laramore) | Benjamin Hatten | 2/7/2025 |
| 346 | 488-9 | Hatten SC Rep. (Raymond) | Re: Camp Lejeune (Raymond) | Benjamin Hatten | 2/7/2025 |
| 347 | 488-10 | Longo Rep. (Criswell) | Specific Causation Expert Report for Jefferson Criswell Thomas Longo, MD | Thomas Longo | 2/7/2025 |
| 348 | 488-11 | Longo MCL (Criswell) | Materials Considered List (Criswell) | Thomas Longo | 2/14/2025 |
| 349 | 488-12 | Longo Rep. (Dyer) | Specific Causation Expert Report for Terry Dyer Thomas Longo, MD | Thomas Longo | 2/7/2025 |
| 350 | 488-13 | Longo MCL (Dyer) | Materials Considered List (Dyer) | Thomas Longo | 2/14/2025 |
| 351 | 488-14 | Longo Rebuttal | Rebuttal Expert Report Thomas Longo, MD | Thomas Longo | 5/14/2025 |
| 352 | 488-15 | Longo 1st Suppl. MCL | Supplemental Materials Considered List (Criswell & Dyer) | Thomas Longo | 6/9/2025 |
| 353 | 488-16 | Longo 2d Suppl. MCL | Second Supplemental Materials Considered (Criswell & Dyer) | Thomas Longo | 6/13/2025 |
| 354 | 489-1 | Sfakianos Rep. (Cagiano) | Specific Causation Expert Report for Mark Cagiano John P Sfakianos, MD | John Sfakianos | 2/7/2025 |
| 355 | 489-2 | Sfakianos MCL (Cagiano) | Materials Considered List (Cagiano) | John Sfakianos | 2/14/2025 |
| 356 | 489-3 | Sfakianos MCL (Laramore) | Materials Considered List (Laramore) | John Sfakianos | 2/14/2025 |
| 357 | 489-4 | Sfakianos Rep. (Laramore) | Specific Causation Expert Report for Jimmy Laramore John P Sfakianos, MD | John Sfakianos | 2/7/2025 |
| 358 | 489-5 | Sfakianos Rebuttal | Rebuttal Expert Report John Sfakianos, MD | John Sfakianos | 5/14/2025 |
| 359 | 489-6 | Sfakianos Suppl. MCL | Supplemental Materials Considered List (Laramore & Cagiano) | John Sfakianos | 6/20/2025 |
| 360 | 489-7 | Kates Rep. (Cagiano) | Re: Cagiano v United States, Case No:7:23-cv-00569 Request for Urologic Oncology Expert Review | Max Kates | 4/8/2025 |
| 361 | 489-8 | Kates Rep. (Criswell) | Re: Criswell v United States, Case No: 7:23-cv-01482-BO Request for Urologic Oncology Expert Revieiv | Max Kates | 4/8/2025 |
| 362 | 489-9 | Kates Rep. (Dyer) | Re: Dyer v United States, Case No: 7:23-cv-00357 Request for Urologic Oncology Expert Review | Max Kates | 4/8/2025 |
| 363 | 489-10 | Kates Rep. (Fiolek) | Re: Robert J Fiolek v United States, Case No: 7:23-cv-00062-D-BM Request for Urologic Oncology Expert Review | Max Kates | 4/8/2025 |
| 364 | 489-11 | Kates Rep. (Laramore) | Re: Laramore v United States, Case No: 7:23-cv-00594 Request for Urologic Oncology Expert Review | Max Kates | 4/8/2025 |
| 365 | 489-12 | Kates Rep. (Raymond) | Re: Raymond v United States, Case No: 7:23-cv-00546 Requst for Urologic Oncology Expert Review | Max Kates | 4/8/2025 |
| 366 | 490-1 | LaKind Rep. (Cagiano) | Expert Report of Judy S LaKind, PhD In the Matter of Cagiano v United States | Judy LaKind | 4/8/2025 |
| 367 | 490-2 | LaKind Rep. (Criswell) | Expert Report of Judy S LaKind, PhD In the Matter of Criswell v United States | Judy LaKind | 4/8/2025 |
| 368 | 490-3 | LaKind Rep. (Dyer) | Expert Report of Judy S LaKind, PhD In the Matter of Dyer v United States | Judy LaKind | 4/8/2025 |
| 369 | 490-4 | LaKind Rep. (Laramore) | Expert Report of Judy S LaKind, PhD In the Matter of Laramore v United States | Judy LaKind | 4/8/2025 |
| 370 | 490-5 | LaKind Rep. (Raymond) | Expert Report of Judy S LaKind, PhD In the Matter of Raymond v United States | Judy LaKind | 4/8/2025 |
| 371 | 490-6 | Bailey Rep. (Cagiano) | Expert Report of Lisa A. Bailey, PhD In the Matter of Mark Cagiano v United States | Lisa Bailey | 4/8/2025 |
| 372 | 490-7 | Miller Rep. (Laramore) | Expert Report of Dr. Henry Miller In the Matter of Laramore v United States | Henry Miller | 4/8/2025 |
| 373 | 490-8 | Bailey Rep. (Carter) | Expert Report of Lisa A. Bailey, PhD In the Matter of Carter v United States | Lisa Bailey | 4/8/2025 |
| 374 | 490-9 | Bailey Rep. (Criswell) | Expert Report of Lisa A. Bailey, PhD In the Matter of Criswell v United States | Lisa Bailey | 4/8/2025 |
| 375 | 490-10 | Bailey Rep. (Dyer) | Expert Report of Lisa A. Bailey, PhD In the Matter of Dyer v United States | Lisa Bailey | 4/8/2025 |
| 376 | 490-11 | Bailey Rep. (Laramore) | Expert Report of Lisa A Bailey, PhD In the Case of: Laramore v United States | Lisa Bailey | 4/8/2025 |
| 377 | 490-12 | Bailey Rep. (Raymond) | Expert Report of Lisa A Bailey, PhD In the Case of: Edward Raymond v United States | Lisa Bailey | 4/8/2025 |
| 378 | 491-2 | Allen Rep. (Tukes) | Expert Report on the Review of Genetic Testing Records for Jacqueline Tukes - Renal Cell Carcinoma | Irving C Allen | 2/7/2025 |
| 379 | 491-3 | Allen Rebuttal (Tukes) | Response to “Expert Report on the Case of Jacqueline Y Tukes for the Department of Justice” prepared by Gail H Vance, MD, dated April 8, 2025 | Irving C Allen | 5/13/2025 |
| 380 | 491-4 | Allen MCL (Tukes) | Materials Considered List for Irving Allen (Tukes) | Irving C Allen | |
| 381 | 491-5 | Allen Suppl. MCL | Supplemental Materials Considered List for Irving Allen (Kidney Cancer) | Irving C Allen | Undated |
| 382 | 491-6 | Cooper Rep. (Mousser) | Specific Causation Expert Report: Frank W Mousser | Matthew Cooper | 2/2/2025 |
| 383 | 491-7 | Cooper Rep. (Tukes) | Specific Causation Expert Report: Jacqueline Tukes | Matthew Cooper | 2/2/2025 |
| 384 | 491-8 | Del Pizzo Rep. (Fancher) | Specific Causation Expert Report: David Fancher | Joseph Del Pizzo | 2/3/2025 |
| 385 | 491-9 | Del Pizzo Rep. (Howard) | Specific Causation Expert Report: Allan Wayne Howard | Joseph Del Pizzo | 2/3/2025 |
| 386 | 491-10 | Del Pizzo Rep. (Mousser) | Specific Causation Expert Report: Frank W Mousser | Joseph Del Pizzo | 2/2/2025 |
| 387 | 491-11 | Del Pizzo Suppl. Rep. (Mousser) | Specific Causation Expert Supplemental Report: Frank W Mousser | Joseph Del Pizzo | 4/8/2025 |
| 388 | 491-12 | Del Pizzo Rebuttal | Specific Causation Expert Supplemental Report | Joseph Del Pizzo | 5/14/2025 |
| 389 | 491-13 | Hoppe Rep. (Howard) | Richard T Hoppe, MD, FACR, FASTRO, FARS (Howard) | Hoppe, Richard | 2/3/2025 |
| 390 | 491-14 | Hoppe MCL (Howard) | Materials Considered List for Richard T Hoppe's Report on Plaintiff Allan W Howard | Hoppe, Richard | 2/14/2025 |
| 391 | 491-15 | Hoppe 1st Suppl. MCL (Howard) | Supplemental Materials Considered List - Dr Richard Hoppe | Hoppe, Richard | 5/29/2025 |
| 392 | 491-16 | Hoppe 2d Suppl. MCL (Howard) | Additional Supplemental Materials Considered List - Dr Richard Hoppe | Hoppe, Richard | 7/24/2025 |
| 393 | 492-2 | Josephson Rep. (Howard) | SPECIFIC CAUSATION EXPERT WITNESS REPORT: ALLAN HOWARD | David Josephson | 2/7/2025 |
| 394 | 492-3 | Josephson Rep. (Tukes) | SPECIFIC CAUSATION EXPERT WITNESS REPORT: JACQUELINE TUKES | David Josephson | 2/7/2025 |
| 395 | 492-4 | Lotan Rep. (Downs) | Specific Causation Expert Report: David Downs | Yair Lotan | 2/6/2025 |
| 396 | 492-5 | Lotan MCL (Downs) | Materials Considered List (Downs) | Yair Lotan | 2/14/2025 |
| 397 | 492-6 | Lotan Rep. (Fancher) | Specific Causation Expert Report: David Fancher | Yair Lotan | 2/5/2025 |
| 398 | 492-7 | Lotan MCL (Fancher) | Materials Considered List (Fancher) | Yair Lotan | 2/14/2025 |
| 399 | 492-8 | Lotan Rebuttal | Specific Causation Rebuttal Report | Yair Lotan | 5/14/2025 |
| 400 | 492-9 | Lotan 1st Suppl. MCL | 1st Suppl. Materials Considered List | Yair Lotan | 5/29/2025 |
| 401 | 492-10 | Lotan 2d Suppl. MCL | 2nd Suppl. Materials Considered List | Yair Lotan | 6/13/2025 |
| 402 | 492-11 | Mallon SC Rep. (Downs) | Specific Causation Report of Timothy M Mallon, MD, MPH, MS For Mr David Downs | Timothy M Mallon | 2/7/2025 |
| 403 | 492-12 | Mallon SC MCL (Downs) | Specific Causation - Downs Materials Considered List | Timothy M Mallon | undated |
| 404 | 492-13 | Mallon SC Rep. (Tukes) | Specific Causation Report of Timothy M Mallon, MD, MPH, MS For Ms Jacqueline Tukes | Timothy M Mallon | 2/7/2025 |
| 405 | 492-14 | Mallon SC MCL (Tukes) | Specific Causation - Tukes Materials Considered List | Timothy M Mallon | undated |
| 406 | 492-15 | Mallon SC 1st Suppl. MCL (Kidney) | Specific Causation - 1st Supp Materials Considered List (Downs and Tukes) | Timothy M Mallon | undated |
| 407 | 492-16 | Mallon SC 2d Suppl. MCL (Kidney) | Specific Causation - 2nd Supp Materials Considered List (Downs and Tukes) | Timothy M Mallon | undated |
| 408 | 492-17 | Mallon SC 3d Suppl. MCL (Kidney) | Specific Causation - 3rd Supp Materials Considered List (Downs and Tukes) | Timothy M Mallon | undated |
| 409 | 492-18 | Mallon SC Rep. Err. | Errata to Phase 3 Expert Reports | Timothy M Mallon | 8/12/2025 |
| 410 | 493-1 | Margulis Rep. (Downs) | Specific Causation Expert Report: David Downs | Vitaly Margulis | 2/7/2025 |
| 411 | 493-2 | Smith Rep. (Howard) | Specific Causation Expert Report for Allan Howard | Armine Smith | 2/7/2025 |
| 412 | 493-3 | Smith Rep. (Mousser) | Specific Causation Expert Report for Frank Mousser | Armine Smith | 2/7/2025 |
| 413 | 493-4 | Smith Suppl. Rep. (Mousser) | Supplemental Specific Causation Expert Report for Frank Mousser | Armine Smith | |
| 414 | 493-5 | Smith Rep. (Tukes) | Specific Causation Expert Report for Patient Jacqueline Tukes | Armine Smith | 2/7/2025 |
| 415 | 493-6 | Smith Rebuttal Rep. | Specific Causation Rebuttal Report | Armine Smith | 2/7/2025 |
| 416 | 493-7 | Weiss Rep. (Fancher) | Specific Causation Expert Report for David Fancher | Matthew Weiss | 2/5/2025 |
| 417 | 493-8 | Weiss MCL | Materials Considered List | Matthew Weiss | 2/14/2025 |
| 418 | 494-1 | LaKind Rep. & Att. (Downs) | Expert Report of Judy S LaKind, PhD In the Matter of Downs v United States | Judy LaKind | 4/8/2025 |
| 419 | 494-2 | LaKind Rep. & Att. (Fancher) | Expert Report of Judy S LaKind, PhD In the Matter of Fancher v United States | Judy LaKind | 4/8/2025 |
| 420 | 494-3 | LaKind Rep. & Att. (Howard) | Expert Report of Judy S LaKind, PhD In the Matter of Howard v United States | Judy LaKind | 4/8/2025 |
| 421 | 494-4 | LaKind Rep. & Att. (Mousser) | Expert Report of Judy S LaKind, PhD In the Matter of Mousser v United States | Judy LaKind | 4/8/2025 |
| 422 | 494-5 | LaKind Rep. & Att. (Tukes) | Expert Report of Judy S LaKind, PhD In the Matter of Tukes v United States | Judy LaKind | 4/8/2025 |
| 423 | 494-6 | Bailey Rep. (Downs) | Expert Report of Lisa A Bailey, PhD In the Case of: David Downs v United States | Lisa Bailey | 4/8/2025 |
| 424 | 494-7 | Bailey Rep. (Fancher) | Expert Report of Lisa A Bailey, PhD In the Case of: David Fancher v United States | Lisa Bailey | 4/8/2025 |
| 425 | 494-8 | Bailey Rep. (Howard) | Expert Report of Lisa A Bailey, PhD In the Case of: Allan Howard v United States | Lisa Bailey | 4/8/2025 |
| 426 | 494-9 | Bailey Rep. (Mousser) | Expert Report of Lisa A Bailey, PhD In the Case of: Frank Mousser v United States | Lisa Bailey | 4/8/2025 |
| 427 | 494-10 | Bailey Rep. (Tukes) | Expert Report of Lisa A Bailey, PhD In the Case of: Jacqueline Tukes v United States | Lisa Bailey | 4/8/2025 |
| 428 | 494-11 | Johnstone Rep. (Mousser) | Re: Frank Mousser | Duncan Johnstone | 4/7/2025 |
| 429 | 494-12 | Johnstone MCL (Mousser) | Materials Considered List (Mousser) | Duncan Johnstone | 4/15/2025 |
| 430 | 494-13 | Johnstone Rep. (Tukes) | Re: Jacqueline J Tukes | Duncan Johnstone | 4/7/2025 |
| 431 | 494-14 | Johnstone MCL (Tukes) | Materials Considered List (Tukes) | Duncan Johnstone | 4/15/2025 |
| 432 | 495-1 | Stadler Rep. (Downs) | Report of Walter Stadler, MD, FACP Downs v United States, 7:23-cv-01145 (EDNC) | Walter Stadler | 4/8/2025 |
| 433 | 495-2 | Stadler MCL (Downs) | Materials Considered List (Downs) | Walter Stadler | 4/15/2025 |
| 434 | 495-3 | Stadler Rep. (Fancher) | Report of Walter Stadler, MD, FACP Fancher v United States, 7:23-cv-00275 (EDNC) | Walter Stadler | 4/8/2025 |
| 435 | 495-4 | Stadler MCL (Fancher) | Materials Considered List (Fancher) | Walter Stadler | 4/15/2025 |
| 436 | 495-5 | Stadler Rep. (Howard) | Report of Walter Stadler, MD, FACP Howard v United States, 7:23-cv-00490 (EDNC) | Walter Stadler | 4/8/2025 |
| 437 | 495-6 | Stadler MCL (Howard) | Materials Considered List (Howard) | Walter Stadler | 4/15/2025 |
| 438 | 495-7 | Stadler Rep. (Mousser) | Report of Walter Stadler, MD, FACP Mousser v United States, 7:23-cv-00667 (EDNC) | Walter Stadler | 4/8/2025 |
| 439 | 495-8 | Stadler Suppl. Rep. (Mousser) | Mousser v United States, 7:23-cv-06667 (EDNC) | Walter Stadler | 5/15/2025 |
| 440 | 495-9 | Stadler MCL (Mousser) | Materials Considered List (Mousser) | Walter Stadler | 4/15/2025 |
| 441 | 495-10 | Stadler Rep. (Tukes) | Report of Walter Stadler, MD, FACP Tukes v United States, 7:23-cv-01553 (EDNC) | Walter Stadler | 4/8/2025 |
| 442 | 495-11 | Stadler MCL (Tukes) | Materials Considered List (Tukes) | Walter Stadler | 4/15/2025 |
| 443 | 495-12 | Stadler Suppl. MCL | 1st Suppl. Materials Considered List | Walter Stadler | 7/9/2025 |
| 444 | 495-13 | Vance Rep. (Tukes) | EXPERT REPORT ON THE CASE OF JACQUELINE Y TUKES FOR THE DEPARTMENT OF JUSTICE GAIL H VANCE, MD | Gail Vance | 4/8/2025 |
| 445 | 495-14 | Vance MCL (Tukes) | Materials Considered List (Tukes) | Gail Vance | 4/15/2025 |
| 446 | 495-15 | Vance Suppl. MCL (Tukes) | 1st Suppl. Materials Considered List | Gail Vance | 7/2/2025 |
| 447 | 495-16 | Miller SC Rep. (Mousser) | FRANK MOUSSER V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 4/8/2025 |
| 448 | 495-17 | Miller SC Suppl. Rep. (Mousser) | FRANK MOUSSER V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION AMENDED EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 6/2/2025 |
| 449 | 495-18 | Miller SC Rep. (Tukes) | JACQUELINE TUKES V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 4/8/2025 |
| 450 | 496-2 | Felsher SC Rep. (Hill) | Specific Causation on Expert Report of Dean W Felsher, MD, PhD | Dean W Felsher | 2/7/2025 |
| 451 | 496-3 | Felsher Am. SC Rep. (Hill) | Specific Causation on Amended Expert Report of Dean W Felsher, MD, PhD | Dean W Felsher | 7/1/2025 |
| 452 | 496-4 | Felsher 1st Suppl. MCL (Hill) | Supplemental Materials Considered List (Hill) | Dean W Felsher | |
| 453 | 496-5 | Felsher 2d Suppl. MCL (Hill) | Supplemental Materials Considered List (Hill) | Dean W Felsher | |
| 454 | 496-6 | Felsher 3d Suppl. MCL (Hill) | Supplemental Materials Considered List (Hill) | Dean W Felsher | |
| 455 | 496-7 | Gondek SC Rep. (Amsler) | Gondek - Specific Causation Report - Karen Amsler | Gondek, Lukasz | 2/7/2025 |
| 456 | 496-8 | Gondek SC Rep. (Connard) | Gondek - Specific Causation Report - Stephen Connard | Gondek, Lukasz | 2/7/2025 |
| 457 | 496-9 | Gondek SC Suppl. MCL (Connard) | Gondek - Specific Causation Supplemental Materials Considered List - Stephen Connard | Gondek, Lukasz | 2/14/2025 |
| 458 | 496-10 | Gondek SC Suppl. MCL (Amsler) | Gondek - Specific Causation Supplemental Materials Considered List - Karen Amsler | Gondek, Lukasz | 2/14/2025 |
| 459 | 496-11 | Laber Rep. (Fiolek) | Specific Causation Expert Report of Damian A Laber, MD, FACP (Fiolek) | Damian Laber | 2/7/2025 |
| 460 | 496-12 | Laber Suppl. MCL (Fiolek) | Dr Damian Laber - Additional Materials Considered February 2025 Specific Causation Expert Report of Damian A Laber, MD, FACP [Robert Fiolek - Leukemia - Case No 7:23-cv-00062] | Damian Laber | 7/3/2025 |
| 461 | 496-13 | Laber Rep. (Gleesing) | Specific Causation Expert Report of Damian A Laber, MD, FACP (Gleesing) | Damian Laber | 2/7/2025 |
| 462 | 496-14 | Laber Suppl. MCL (Gleesing) | Dr Damian Laber - Additional Materials Considered February 2025 Specific Causation Expert Report of Damian A Laber, MD, FACP [Joseph Gleesing - Leukemia - Case No 7:23-cv-01486] | Damian Laber | 7/3/2025 |
| 463 | 496-15 | LaKind Rep. (Amsler) | Expert Report of Judy S LaKind, PhD In the Matter of Amsler v United States | Judy LaKind | 4/8/2025 |
| 464 | 496-16 | LaKind Rep. (Connard) | Expert Report of Judy S LaKind, PhD In the Matter of Connard v United States | Judy LaKind | 4/8/2025 |
| 465 | 496-17 | LaKind Rep. (Fiolek) | Expert Report of Judy S LaKind, PhD In the Matter of Fiolek v United States | Judy LaKind | 4/8/2025 |
| 466 | 496-18 | LaKind Rep. (Gleesing) | Expert Report of Judy S LaKind, PhD In the Matter of Gleesing v United States | Judy LaKind | 4/8/2025 |
| 467 | 496-19 | LaKind Rep. (Hill) | Expert Report of Judy S LaKind, PhD In the Matter of Hill v United States | Judy LaKind | 4/8/2025 |
| 468 | 497-1 | Bailey Rep. (Amsler) | Expert Report of Lisa A Bailey, PhD In the Case of: Karen Amsler v United States | Lisa Bailey | 4/8/2025 |
| 469 | 497-2 | Bailey Rep. (Connard) | Expert Report of Lisa A Bailey, PhD In the Case of: Vivian Connard (as Rep.resentative of Stephen Connard) v United States | Lisa Bailey | 4/8/2025 |
| 470 | 497-3 | Bailey Rep. (Fiolek) | Expert Report of Lisa A Bailey, PhD In the Case of: Robert Fiolek v United States | Lisa Bailey | 4/8/2025 |
| 471 | 497-4 | Bailey Rep. (Gleesing) | Expert Report of Lisa A Bailey, PhD In the Case of: Joseph Gleesing v United States | Lisa Bailey | 4/8/2025 |
| 472 | 497-5 | Bailey Rep. (Hill) | Expert Report of Lisa A Bailey, PhD In the Case of: Bruce Hill v United States | Lisa Bailey | 4/8/2025 |
| 473 | 497-6 | Erba Rep. (Amsler) | Erba - Specific Causation Report - Karen Amsler | Erba, Harry | 4/8/2025 |
| 474 | 497-7 | Erba Rep. (Connard) | Erba - Specific Causation Report - Stephen Connard | Erba, Harry | 4/8/2025 |
| 475 | 497-8 | Erba Rep. (Fiolek) | Erba - Specific Causation Report - Robert Fiolek | Erba, Harry | 4/8/2025 |
| 476 | 497-9 | Erba Rep. (Gleesing) | Erba - Specific Causation Report - Joseph Gleesing | Erba, Harry | 4/8/2025 |
| 477 | 497-10 | Erba Rep. (Hill) | Erba - Specific Causation Report - Bruce Hill | Erba, Harry | 4/8/2025 |
| 478 | 497-11 | Erba 1st Suppl. MCL | Erba - Supplemental Materials Considered List to Leukemia Plaintiffs - 1 | Erba, Harry | 4/16/2025 |
| 479 | 497-12 | Erba 2d Suppl. MCL | Erba - Supplemental Materials Considered List to Leukemia Plaintiffs - 2 | Erba, Harry | 7/14/2025 |
| 480 | 497-13 | Erba 3d Suppl. MCL | Erba - Supplemental Materials Considered List to Leukemia Plaintiffs - 3 | Erba, Harry | 7/21/2025 |
| 481 | 497-14 | Miller SC Rep. (Hill) | BRUCE HILL V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 4/8/2025 |
| 482 | 498-1 | Felsher SC Rep. (Keller) | Specific Causation Expert Report of Dean W Felsher, MD, PhD: Scott Richard Keller v United States of America US District Court for Eastern District of NC, Southern Division Case No 7:23-cv-01501 | Dean W Felsher | 2/7/2025 |
| 483 | 498-2 | Felsher 1st Suppl. MCL (Keller) | Supplemental Materials Considered List (Keller) | Dean W Felsher | |
| 484 | 498-3 | Felsher 2d Suppl. MCL (Keller) | Supplemental Materials Considered List (Keller) | Dean W Felsher | |
| 485 | 498-4 | Felsher 3d Suppl. MCL (Keller) | Supplemental Materials Considered List (Keller) | Dean W Felsher | |
| 486 | 498-5 | Hoppe Rep. (Davis) | Specific Causation Expert Report of Richard T Hoppe, MD, FACR, FASTRO, FARS Cometto J Davis v United States of America US District Court for Eastern District of NC, Southern Division Case No 7:23-cv-00043 | Hoppe, Richard | 2/6/2025 |
| 487 | 498-6 | Hoppe MCL (Davis) | Additional Materials Considered - Expert Report of Richard T Hoppe (Davis) | Hoppe, Richard | 2/14/2025 |
| 488 | 498-7 | Hoppe 1st Suppl. MCL (Davis) | First Supplemental Materials Considered List - Expert Report of Richard T Hoppe (Davis) | Hoppe, Richard | 6/3/2025 |
| 489 | 498-8 | Hoppe 2d Suppl. MCL (Davis) | Second Supplemental Materials Considered List - Expert Report of Richard T Hoppe (Davis) | Hoppe, Richard | 7/24/2025 |
| 490 | 498-9 | Hu SC Rep. (Carter) | Specific Causation Expert Report of Howard Hu, MD, MPH, ScD Frances Carter (for the Estate of Ronald Lee Carter) v United States of America US District Court for Eastern District of NC, Southern Division Case No 7:23-cv-01565 | Howard Hu | 2/7/2025 |
| 491 | 498-10 | Hu SC 1st Suppl. MCL (Carter) | NHL - SC Expert Report of Howard Hu - Additional Materials Considered - Ronald Carter | Howard Hu | 2/14/2025 |
| 492 | 498-11 | Hu SC 2d Suppl. MCL (Carter) | Howard Hu - 4-24-2025 Supplemental Materials Considered List to SC Carter NHL Report | Howard Hu | 4/24/2025 |
| 493 | 498-12 | Hu SC 3d Suppl. MCL (Carter) | Howard Hu - 4-29-2025 Supplemental Materials Considered List to SC Carter NHL Report | Howard Hu | 4/29/2025 |
| 494 | 498-13 | Hu SC Rebuttal Ambinder (Carter) | Rebuttal to Report of Dr Richard F Ambinder re: Ronald Lee Carter | Howard Hu | 5/16/2025 |
| 495 | 498-14 | Hu SC Rebuttal Bailey (Carter) | Rebuttal to Report of Dr Lisa A Bailey re: Ronald Lee Carter | Howard Hu | 5/16/2025 |
| 496 | 499-1 | Hu SC Rep. (Kidd) | Specific Causation Expert Report of Howard Hu, MD, MPH, ScD Robert Kidd v United States of America US District Court for Eastern District of NC, Southern Division Case No 7:23-cv-01489 | Howard Hu | 2/7/2025 |
| 497 | 499-2 | Hu SC 1st Suppl. MCL (Kidd) | NHL - SC Expert Report of Howard Hu - Additional Materials Considered - Robert Kidd | Howard Hu | 2/14/2025 |
| 498 | 499-3 | Hu SC 2d Suppl. MCL (Kidd) | Howard Hu - 4-24-2025 Supplemental Materials Considered List to SC Kidd NHL Report | Howard Hu | 4/24/2025 |
| 499 | 499-4 | Hu SC 3d Suppl. MCL (Kidd) | Howard Hu - 4-29-2025 Supplemental Materials Considered List to SC Kidd NHL Report | Howard Hu | 4/29/2025 |
| 500 | 499-5 | Hu SC Rebuttal Ambinder (Kidd) | Rebuttal to Report of Dr Richard F Ambinder re: Robert Arnold Kidd | Howard Hu | 5/16/2025 |
| 501 | 499-6 | Hu SC Rebuttal Bailey (Kidd) | Rebuttal to Report of Dr Lisa A Bailey re: Robert Arnold Kidd | Howard Hu | 5/16/2025 |
| 502 | 499-7 | Michaels Rep. (Vidana) | Specific Causation Expert Report of Paul J Michaels, MD Jose Vidana v United States of America US District Court for Eastern District of NC, Southern Division Case No 7:23-CV-01575 | Paul J Michaels | 2/7/2025 |
| 503 | 499-8 | Michaels MCL (Vidana) | Additional Materials Considered - Expert Report of Paul J Michaels (Vidana) | Paul J Michaels | 2/14/2025 |
| 504 | 499-9 | Michaels 1st Suppl. MCL (Vidana) | First Supplemental Materials Considered List - Expert Report of Paul J Michaels (Vidana) | Paul J Michaels | 4/24/2025 |
| 505 | 499-10 | Michaels 2d Suppl. MCL (Vidana) | Second Supplemental Materials Considered List - Expert Report of Paul J Michaels (Vidana) | Paul J Michaels | 7/30/2025 |
| 506 | 500-1 | LaKind Rep. & Att. (Carter) | Expert Report of Judy S LaKind, PhD In the Matter of Carter v United States | Judy LaKind | 4/8/2025 |
| 507 | 500-2 | LaKind Rep. & Att. (Davis) | Expert Report of Judy S LaKind, PhD In the Matter of Davis v United States | Judy LaKind | 4/8/2025 |
| 508 | 500-3 | LaKind Rep. & Att. (Keller) | Expert Report of Judy S LaKind, PhD In the Matter of Keller v United States | Judy LaKind | 4/8/2025 |
| 509 | 500-4 | LaKind Rep. & Att. (Kidd) | Expert Report of Judy S LaKind, PhD In the Matter of Kidd v United States | Judy LaKind | 4/8/2025 |
| 510 | 500-5 | LaKind Rep. (Vidana) | Expert Report of Judy S LaKind, PhD In the Matter of Vidana v United States | Judy LaKind | 4/8/2025 |
| 511 | 500-6 | Bailey Rep. (Davis) | Expert Report of Lisa A Bailey, PhD In the Case of: Cometto Davis v United States | Lisa Bailey | 4/8/2025 |
| 512 | 500-7 | Bailey Rep. (Keller) | Expert Report of Lisa A Bailey, PhD In the Case of: Scott Keller v United States | Lisa Bailey | 4/8/2025 |
| 513 | 500-8 | Bailey Rep. (Kidd) | Expert Report of Lisa A Bailey, PhD In the Case of: Robert Kidd v United States | Lisa Bailey | 4/8/2025 |
| 514 | 500-9 | Bailey Rep. (Vidana) | Expert Report of Lisa A Bailey, PhD In the Case of: Jose Vidana v United States | Lisa Bailey | 4/8/2025 |
| 515 | 501-1 | Ambinder Rep. (Carter) | Expert Report of Richard F Ambinder, MD, PhD: Estate of Ronald Carter v United States, No. 7:23-cv-01565 | Richard Ambinder | 4/8/2025 |
| 516 | 501-2 | Ambinder Rep. (Davis) | Expert Report of Richard F Ambinder, MD, PhD: Cometto Davis v United States, No. 7:23-cv-00043 | Richard Ambinder | 4/8/2025 |
| 517 | 501-3 | Ambinder Rep. (Howard) | Expert Report of Richard F Ambinder, MD, PhD: Allan Howard v United States, No. 7:23-cv-00490 | Richard Ambinder | 4/8/2025 |
| 518 | 501-4 | Ambinder Rep. (Keller) | Expert Report of Richard F Ambinder, MD, PhD: Scott Keller v United States, No. 7:23-cv-01501 | Richard Ambinder | 4/8/2025 |
| 519 | 501-5 | Ambinder Rep. (Kidd) | Expert Report of Richard F Ambinder, MD, PhD: Robert Kidd v United States, No. 7:23-cv-01489 | Richard Ambinder | 4/8/2025 |
| 520 | 501-6 | Ambinder Rep. (Vidana) | Expert Report of Richard F Ambinder, MD, PhD: Jose Vidana v United States, No. 7:23-cv-01575 | Richard Ambinder | 4/8/2025 |
| 521 | 501-7 | Ambinder MCL Pt A | Materials Considered List Attachment A | Richard Ambinder | 4/8/2025 |
| 522 | 501-8 | Ambinder MCL Pt B | Materials Considered List Attachment B | Richard Ambinder | 4/8/2025 |
| 523 | 501-9 | Ambinder Suppl. MCL | Supplemental Materials Considered List | Richard Ambinder | |
| 524 | 501-10 | D'Alessio Rep. (Keller) | Expert Report of David A D'Alessio, MD Scott Keller v United States 7:23-cv-01501 United States District Court for the Eastern District of North Carolina | David D'Alessio | 4/8/2025 |
| 525 | 502-2 | Andruska Rep. (Rothchild) | Expert Report of Kristin Andruska, MD, PhD: Rothchild v United States, No. 7:23-cv-00858-D-KS | Kristin Andruska | 2/6/2025 |
| 526 | 502-3 | Andruska 1st Suppl. MCL | Amended Materials Considered List of Kristin Andruska, MD, PhD | Kristin Andruska | 2/14/2025 |
| 527 | 502-4 | Andruska 2d Suppl. MCL | Supplemental Materials Considered List of Kristin Andruska, MD, PhD | Kristin Andruska | 7/7/2025 |
| 528 | 502-5 | Barbano Rep. (McElhiney) | Expert Witness Report: Gary McElhiney | Richard Barbano | 2/7/2025 |
| 529 | 502-6 | Barbano Rep. (Peterson) | Expert Witness Report: Edgar Peterson IV | Richard Barbano | 2/7/2025 |
| 530 | 502-7 | Barbano 1st Suppl. MCL | Supplemental Materials Considered | Richard Barbano | 5/6/2025 |
| 531 | 502-8 | Barbano 2d Suppl. MCL | Second Supplemental Materials Considered | Richard Barbano | 5/29/2025 |
| 532 | 502-9 | Barbano 3d Suppl. MCL | Third Supplemental Materials Considered | Richard Barbano | 6/23/2025 |
| 533 | 502-10 | Schwarz Rep. (Sparks) | Dr Heidi Schwarz Specific Causation Expert Report re Richard Sparks | Heidi Schwarz | 2/5/2025 |
| 534 | 502-11 | Schwarz Rep. (Welch) | Dr Heidi Schwarz Specific Causation Expert Report re Robert Welch | Heidi Schwarz | 2/5/2025 |
| 535 | 502-12 | Schwarz MCL | Materials Considered List | Heidi Schwarz | 2/14/2025 |
| 536 | 502-13 | Schwarz 1st Suppl. MCL | Supplemental Materials Considered List | Heidi Schwarz | 5/6/2025 |
| 537 | 502-14 | Schwarz 2d Suppl. MCL | Second Supplemental Materials Considered List | Heidi Schwarz | 6/23/2025 |
| 538 | 503-1 | LaKind Rep. (McElhiney) | Expert Report of Judy S LaKind, PhD In the Matter of McElhiney v United States | Judy LaKind | 4/8/2025 |
| 539 | 503-2 | LaKind Rep. (Peterson) | Expert Report of Judy S LaKind, PhD In the Matter of Peterson v United States | Judy LaKind | 4/8/2025 |
| 540 | 503-3 | LaKind Rep. (Rothchild) | Expert Report of Judy S LaKind, PhD In the Matter of Rothchild v United States | Judy LaKind | 4/8/2025 |
| 541 | 503-4 | LaKind Rep. (Sparks) | Expert Report of Judy S LaKind, PhD In the Matter of Sparks v United States | Judy LaKind | 4/8/2025 |
| 542 | 503-5 | LaKind Rep. (Welch) | Expert Report of Judy S LaKind, PhD In the Matter of Welch v United States | Judy LaKind | 4/8/2025 |
| 543 | 503-6 | Bailey Rep. (McElhiney) | Expert Report of Lisa A Bailey, PhD In the Case of: Gary McElhiney v United States | Lisa Bailey | 4/8/2025 |
| 544 | 503-7 | Bailey Rep. (Peterson) | Expert Report of Lisa A Bailey, PhD In the Case of: Edgar Peterson v United States | Lisa Bailey | 4/8/2025 |
| 545 | 503-8 | Bailey Rep. (Rothchild) | Expert Report of Lisa A Bailey, PhD In the Case of: Diane Rothchild v United States | Lisa Bailey | 4/8/2025 |
| 546 | 503-9 | Bailey Rep. (Sparks) | Expert Report of Lisa A Bailey, PhD In the Case of: Richard Sparks v United States | Lisa Bailey | 4/8/2025 |
| 547 | 503-10 | Bailey Rep. (Welch) | Expert Report of Lisa A Bailey, PhD In the Case of: Robert Welch v United States | Lisa Bailey | 4/8/2025 |
| 548 | 503-11 | Gollomp Rep. (Rothchild) | Expert Report of Stephen M Gollomp, MD DIANE ROTHCHILD v UNITED STATES OF AMERICA Case No 7:23-CV-00858 | Stephen Gollomp | 5/8/2025 |
| 549 | 503-12 | Gollomp Rep. (Welch) | Expert Report of Stephen M Gollomp, MD ROBERT WELCH v UNITED STATES OF AMERICA Case No 7:23-CV-01503 | Stephen Gollomp | 5/8/2025 |
| 550 | 504-1 | Young Rep. (McElhiney) | Expert Report of Michael Young, MD, MPhil In the Case of: Gary L McElhiney v United States, Case No 7:23-cv-01368 | Michael Young | 5/8/2025 |
| 551 | 504-2 | Young MCL (McElhiney) | Materials Considered List of Michael Young, MD, MPhil In the Case of: Gary L McElhiney v United States, Case No 7:23-cv-01368 | Michael Young | 5/15/2025 |
| 552 | 504-3 | Young Suppl. MCL (McElhiney) | Supplemental Materials Considered List of Michael Young, MD, MPhil In the Case of: Gary L McElhiney v United States, Case No 7:23-cv-01368 | Michael Young | 7/17/2025 |
| 553 | 504-4 | Young Rep. (Peterson) | Expert Report of Michael Young, MD, MPhil In the Case of: Edgar A Peterson, IV, v United States, Case No 7:23-cv-01576 | Michael Young | 5/8/2025 |
| 554 | 504-5 | Young MCL (Peterson) | Materials Considered List of Michael Young, MD, MPhil In the Case of: Edgar A Peterson, IV, v United States, Case No 7:23-cv-01576 | Michael Young | 5/15/2025 |
| 555 | 504-6 | Young Suppl. MCL (Peterson) | Supplemental Materials Considered List of Michael Young, MD, MPhil In the Case of: Edgar A Peterson, IV, v United States, Case No 7:23-cv-01576 | Michael Young | 7/17/2025 |
| 556 | 504-7 | Young Rep. (Sparks) | Expert Report of Michael Young, MD, MPhil In the Case of Richard Sparks v United States, 7:23-cv-00682 | Michael Young | 5/8/2025 |
| 557 | 504-8 | Young MCL (Sparks) | Materials Considered List of Michael Young, MD, MPhil In the Case of: Richard Sparks v United States, 7:23-cv-00682 | Michael Young | 5/15/2025 |
| 558 | 504-9 | Young Suppl. MCL (Sparks) | Supplemental Materials Considered List of Michael Young, MD, MPhil In the Case of: Richard Sparks v United States, 7:23-cv-00682 | Michael Young | 7/17/2025 |
| 559 | 505-1 | Brod Rep. (McElhiney) | Expert Report of Andrew Brod, PhD In the matter of Gary Layne McElhiney, Sr v United States of America Case No 7:23-CV-01368-BO | Andrew Brod | 5/8/2025 |
| 560 | 505-2 | Brod Rep. (Peterson) | Expert Report of Andrew Brod, PhD In the matter of Edgar Allen Peterson, IV v United States of America Case No 7:23-CV-01576 | Andrew Brod | 5/8/2025 |
| 561 | 505-3 | Brod Rep. (Rothchild) | Expert Report of Andrew Brod, PhD In the matter of Diane L Rothchild v United States of America Case No 7:23-CV-00858 | Andrew Brod | 5/8/2025 |
| 562 | 505-4 | Brod Rep. (Sparks) | Expert Report of Andrew Brod, PhD In the matter of Richard Sparks v United States of America Case No 7:23-CV-00682 | Andrew Brod | 5/8/2025 |
| 563 | 505-5 | Brod Rep. (Welch) | Expert Report of Andrew Brod, PhD In the matter of Robert Welch v United States of America Case No 7:23-CV-01503 | Andrew Brod | 5/8/2025 |
| 564 | 505-6 | Miller SC Rep. (McElhiney) | GARY MCELHINEY V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 5/8/2025 |
| 565 | 505-7 | Miller SC Rep. (Peterson) | EDGAR PETERSON V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 5/8/2025 |
| 566 | 505-8 | Miller SC Rep. (Rothchild) | DIANE ROTHCHILD V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 5/8/2025 |
| 567 | 505-9 | Miller SC Rep. (Sparks) | RICHARD SPARKS V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 5/8/2025 |
| 568 | 505-10 | Miller SC Rep. (Welch) | ROBERT WELCH V UNITED STATES OF AMERICA CAMP LEJEUNE WATER LITIGATION EXPERT REPORT OF DR HENRY MILLER | Henry Miller | 5/8/2025 |
| 569 | 506-2 | Reynolds Rep. | Cumulative Exposure Expert Report Kelly A Reynolds, MSPH, PhD | Kelly Reynolds | 2/7/2025 |
| 570 | 506-3 | Reynolds 1st Suppl. MCL | Supplemental Materials Considered | Kelly Reynolds | |
| 571 | 506-4 | Reynolds 2d Suppl. MCL | Second Supplemental Materials Considered | Kelly Reynolds | |
| 572 | 506-5 | Reynolds Rep. Err. (Cagiano) | ERRATA – February 7, 2025 Expert Report of Kelly A Reynolds, PhD Appendix 1, Mark Cagiano Calculations, Chart 3 and Exposure Data Summary | Kelly Reynolds | undated |
| 573 | 506-6 | Reynolds Appx (Dyer) | (Corrected) Appendix 3 Terry F Dyer (Bladder Cancer) | Kelly Reynolds | undated |
| 574 | 506-7 | Reynolds Appx (Connard) | (Corrected) Appendix 12 Vivian Connard: For Estate of Stephen Matthew Connard (Leukemia) | Kelly Reynolds | undated |
| 575 | 506-8 | Reynolds Appx (Hill) | (Corrected) Appendix 15 Bruce Wayne Hill (Leukemia) | Kelly Reynolds | undated |
| 576 | 506-9 | Schuhmann Rebuttal (Bailey) | Rebuttal Report by Richard J Schuhmann, PhD: Observations regarding expert reports of Lisa A Bailey, PhD | Richard J Schuhmann | 5/13/2025 |
| 577 | 506-10 | Schuhmann Rebuttal (LaKind) | Rebuttal Report by Richard J Schuhmann, PhD: Observations regarding the expert reports of Judy S LaKind, PhD | Richard J Schuhmann | 5/13/2025 |
| 578 | 506-11 | LaKind Rep. Err. | Errata - Expert Report of Judy S LaKind, PhD | Judy LaKind | |
| 579 | 506-12 | LaKind Suppl. Rep. | Supplemental Report | Judy LaKind | |
| 580 | 506-13 | LaKind Suppl. MCL | Supplemental Materials Considered List | Judy LaKind | |
| 581 | 507-2 | Bird SC Dep. Tr. | Bird - Specific Causation Deposition Transcript | Bird, Steven | 7/18/2025 |
| 582 | 507-3 | Bivins Dep. Tr. | Deposition Transcript | Vincent Bivins | 6/27/2025 |
| 583 | 507-4 | Hatten SC Dep. Tr. | Deposition Transcript | Benjamin Hatten | 7/7/2025 |
| 584 | 507-5 | Longo Dep. Tr. | Deposition Transcript | Thomas Longo | 6/16/2025 |
| 585 | 507-6 | Sfakianos Dep. Tr. | Deposition Transcript | John Sfakianos | 7/2/2025 |
| 586 | 507-7 | Kates Dep. Tr. | Deposition Transcript | Max Kates | 7/11/2025 |
| 587 | 507-8 | Allen Dep. Tr. | Deposition Transcript | Irving C Allen | 6/17/2025 |
| 588 | 507-9 | Cooper Dep. Tr. | Deposition Transcript | Matthew Cooper | 7/10/2025 |
| 589 | 507-10 | Del Pizzo Dep. Tr. | Deposition Transcript | Joseph Del Pizzo | 7/30/2025 |
| 590 | 507-11 | Hoppe Dep. Tr. | Deposition Transcript | Hoppe, Richard | 6/9/2025 |
| 591 | 507-12 | Hoppe Dep. Err. | 6/9/2025 Deposition Errata | Hoppe, Richard | |
| 592 | 508-1 | Josephson Dep. Tr. | Deposition Transcript | David Josephson | 6/18/2025 |
| 593 | 508-2 | Lotan Dep. Tr. | Deposition Transcript | Yair Lotan | 7/14/2025 |
| 594 | 508-3 | Mallon SC Dep. Tr. | Deposition Transcript | Timothy M Mallon | 6/24/2025 |
| 595 | 508-4 | Margulis Dep. Tr. | Deposition Transcript | Vitaly Margulis | 7/11/2025 |
| 596 | 508-5 | Michaels Dep. Tr. | Deposition Transcript | Paul Michaels | 8/6/2025 |
| 597 | 508-6 | Smith Dep. Tr. | Deposition Transcript | Armine Smith | 7/2/2025 |
| 598 | 508-7 | Weiss Dep. Tr. | Deposition Transcript | Matthew Weiss | 6/30/2025 |
| 599 | 508-8 | Johnstone Dep. Tr. | Deposition Transcript | Duncan Johnstone | 6/20/2025 |
| 600 | 508-9 | Stadler Dep. Tr. | Deposition Transcript | Walter Stadler | 7/16/2025 |
| 601 | 508-10 | Vance Dep. Tr. | Deposition Transcript | Gail Vance | 7/8/2025 |
| 602 | 508-11 | Hu SC Dep. Tr. | Deposition Transcript - Specific Causation | Howard Hu | 7/23/2025 |
| 603 | 509-1 | Gondek SC Dep. Tr. | Gondek - Specific Causation Deposition Transcript | Gondek, Lukasz | 6/12/2025 |
| 604 | 509-2 | Gondek SC Dep. Err. | Gondek - Specific Causation Deposition Errata | Gondek, Lukasz | 7/23/2025 |
| 605 | 509-3 | D'Alessio Dep. Tr. | Deposition Transcript | David D'Alessio | 6/25/2025 |
| 606 | 509-4 | Felsher SC Dep. Tr. | Deposition Transcript | Dean W Felsher | 7/10/2025 |
| 607 | 509-5 | Laber Dep. Tr. | Deposition Transcript | Damian Laber | 7/9/2025 |
| 608 | 509-6 | Erba Dep. Tr. | Erba - Specific Causation Deposition Transcript | Erba, Harry | 7/23/2025 |
| 609 | 509-7 | Andruska Dep. Tr. | Deposition Transcript of Kristin Andruska MD PhD | Kristin Andruska | 7/8/2025 |
| 610 | 509-8 | Barbano Dep. Tr. | Deposition Transcript | Richard Barbano | 6/30/2025 |
| 611 | 509-9 | Schwarz Dep. Tr. | Deposition Transcript | Heidi Schwarz | 7/1/2025 |
| 612 | 510-1 | Young Dep. Tr. | Deposition Transcript | Michael Young | 7/24/2025 |
| 613 | 510-2 | Reynolds Dep. Tr. | Deposition Transcript | Kelly Reynolds | 6/25/2025 |
| 614 | 510-3 | Gollomp Dep. Tr. | Deposition Transcript | Stephen Gollomp | 7/25/2025 |
| 615 | 510-4 | Reynolds 2d Dep. Tr. | Deposition Transcript | Kelly Reynolds | 8/12/2025 |
| 616 | 517-2 | Reynolds Dep. Err. | Deposition Errata | Kelly Reynolds | 8/15/2025 |
| 617 | 517-3 | LaKind Dep. Tr. | Deposition Transcript | Judy LaKind | 7/17/2025 |
| 618 | 510-7 | Bailey Dep. Tr. | Deposition Transcript | Lisa Bailey | 7/9/2025 |
| 619 | 510-8 | Bailey Dep. Err. | Deposition Errata | Lisa Bailey | 8/14/2025 |